Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 590 articles:
HTML format
Text format



Single Articles


    May 2016
  1. CYSOUW MC, Kramer GM, Hoekstra OS, Frings V, et al
    Accuracy and precision of partial volume correction in oncological PET/CT studies.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173831.
    PubMed     Text format     Abstract available


  2. WU Y, Yang W, Lu L, Lu Z, et al
    Prediction of CT Substitutes from MR Images Based on Local Diffeomorphic Mapping for Brain PET Attenuation Correction.
    J Nucl Med. 2016 May 26. pii: jnumed.115.163121.
    PubMed     Text format     Abstract available


  3. DERLIN T, Alchalby H, Bannas P, Laqmani A, et al
    Serial 18F-fluorodeoxyglucose positron emission tomography for monitoring treatment response after allogeneic stem cell transplantation for myelofibrosis.
    J Nucl Med. 2016 May 26. pii: jnumed.115.166348.
    PubMed     Text format     Abstract available


  4. KIESS A, Minn IL, Vaidyanathan G, Hobbs RF, et al
    (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted alpha-Particle Radiopharmaceutical Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174300.
    PubMed     Text format     Abstract available


  5. LARIMER BM, Wehrenberg-Klee E, Caraballo A, Mahmood U, et al
    Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173930.
    PubMed     Text format     Abstract available


  6. BODET-MILIN C, Faivre-Chauvet A, Carlier T, Rauscher A, et al
    Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial.
    J Nucl Med. 2016 May 26. pii: jnumed.116.172221.
    PubMed     Text format     Abstract available


  7. HOSTETLER ED, Walji AM, Zeng Z, Miller P, et al
    Preclinical characterization of 18F-MK-6240, a promising positron emission tomography (PET) tracer for in vivo quantification of human neurofibrillary tangles (NFTs).
    J Nucl Med. 2016 May 26. pii: jnumed.115.171678.
    PubMed     Text format     Abstract available


  8. LEITHNER D, Baltzer P, Magometschnigg H, Wengert G, et al
    Quantitative Assessment of Breast Parenchymal Uptake in 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174904.
    PubMed     Text format     Abstract available


  9. ORY D, Celen S, Gijsbers R, Van Den Haute C, et al
    Preclinical evaluation of a P2X7 receptor selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in non-human primates.
    J Nucl Med. 2016 May 19. pii: jnumed.115.169995.
    PubMed     Text format     Abstract available


  10. JENTZEN W, Verschure F, van Zon A, van de Kolk R, et al
    Response Assessment of Bone Metastases from Differentiated Thyroid Cancer Patients in the Initial Radioiodine Treatment Using Iodine-124 PET Imaging.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170571.
    PubMed     Text format     Abstract available


  11. DILSIZIAN V
    Highlights from the Updated Joint ASNC/SNMMI PET Myocardial Perfusion and Metabolism Clinical Imaging Guidelines.
    J Nucl Med. 2016 May 19. pii: jnumed.116.176214.
    PubMed     Text format    


  12. CHEN L, Nabulsi N, Naganawa M, Zasadny K, et al
    Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171454.
    PubMed     Text format     Abstract available


  13. HARALAMPIEVA D, Betzel T, Dinulovic I, Salemi S, et al
    Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170548.
    PubMed     Text format     Abstract available


  14. ENGLAND CG, Ehlerding EB, Cai W
    Imaging the biodistribution and performance of transplanted stem cells with PET.
    J Nucl Med. 2016 May 19. pii: jnumed.116.173963.
    PubMed     Text format    


  15. FAHNERT J, Purz S, Javers JS, Heyde CE, et al
    The use of simultaneous 18F-FDG-PET/MRI for the detection of spondylodiscitis.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171561.
    PubMed     Text format     Abstract available


  16. OOSTING SF, van Asselt SJ, Brouwers AH, Bongaerts AH, et al
    89Zr-bevacizumab PET visualizes disease manifestations in patients with von Hippel-Lindau disease.
    J Nucl Med. 2016 May 12. pii: jnumed.115.167643.
    PubMed     Text format     Abstract available


  17. ULANER GA, Hyman D, Ross D, Corben A, et al
    Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using the 89Zr-DFO-trastuzumab PET/CT.
    J Nucl Med. 2016 May 5. pii: jnumed.115.172031.
    PubMed     Text format     Abstract available


  18. SHCHERBININ S, Schwarz AJ, Joshi AD, Navitsky M, et al
    Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer's disease.
    J Nucl Med. 2016 May 5. pii: jnumed.115.170027.
    PubMed     Text format     Abstract available


  19. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Variation of Specific Activities of Ga-68-Aquibeprin and Ga-68-Avebetrin Enables Selective PET-Imaging of Different Expression Levels of Integrins alpha5beta1 and alphavbeta3.
    J Nucl Med. 2016 May 5. pii: jnumed.116.173948.
    PubMed     Text format     Abstract available


  20. CONVERT L, Lebel R, Gascon S, Fontaine R, et al
    Real Time Microfluidic Blood Counting System for PET and SPECT Preclinical Pharmacokinetic Studies.
    J Nucl Med. 2016 May 5. pii: jnumed.115.162768.
    PubMed     Text format     Abstract available


  21. RUHLMANN M, Jentzen W, Ruhlmann V, Pettinato C, et al
    High Level of Agreement between Pretherapeutic 124I PET and Intratherapeutic 131I Images in Detecting Iodine-positive Thyroid Cancer Metastases.
    J Nucl Med. 2016 May 5. pii: jnumed.115.169649.
    PubMed     Text format     Abstract available


    April 2016
  22. HARMS HJ, Hansson NH, Tolbod LP, Kim WY, et al
    Automatic extraction of myocardial mass and volumes using parametric images from dynamic non-gated PET.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.170613.
    PubMed     Text format     Abstract available


  23. BLAUFOX MD
    PET Measurement of Renal GFR: Is there a role in Nuclear Medicine.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174607.
    PubMed     Text format    


  24. HUMBERT O, Riedinger JM, Vrigneaud JM, Kanoun S, et al
    18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.172759.
    PubMed     Text format     Abstract available


  25. JIANG S, Pogue B
    Invited Perspective for: "Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT".
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174367.
    PubMed     Text format    


  26. NAGANAWA M, Waterhouse RN, Nabulsi NB, Lin SF, et al
    First in human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.166850.
    PubMed     Text format     Abstract available


  27. KRAMER GM, Frings V, Hoetjes N, Hoekstra OS, et al
    Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170225.
    PubMed     Text format     Abstract available


  28. KO GB, Yoon HS, Kim KY, Lee MS, et al
    Simultaneous multi-parametric PET/MRI with silicon photomultiplier PET and ultra-high field MRI for small animal imaging.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.170019.
    PubMed     Text format     Abstract available


  29. FREY KA, Koeppe R
    Invited Perspective for Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Apr 14. pii: jnumed.116.173989.
    PubMed     Text format    


  30. WU J, Lin SF, Gallezot JD, Chan C, et al
    Quantitative analysis of dynamic 123I-mIBG SPECT imaging data in healthy humans with a population-based metabolite correction method.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.171710.
    PubMed     Text format     Abstract available


  31. WEHRENBERG-KLEE E, Turker NS, Heidari P, Larimer BM, et al
    Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.169417.
    PubMed     Text format     Abstract available


  32. TADE FI, Cohen MA, Styblo TM, Odewole OA, et al
    Anti-3-[18F] FACBC (Fluciclovine) PET-CT of Breast Cancer An Exploratory Study.
    J Nucl Med. 2016 Apr 7. pii: jnumed.115.171389.
    PubMed     Text format     Abstract available


  33. FAHEY FH, Ziniel SI, Manion D, Baker A, et al
    Administered Activities for Pediatric Nuclear Medicine Procedures and the Impact of the 2010 North American Guidelines on General Hospitals in the United States.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172148.
    PubMed     Text format     Abstract available


  34. BRACKHAN M, Bascunana P, Postema JM, Ross TL, et al
    Serial quantitative TSPO-targeted PET reveals peak microglial activation up to two weeks after an epileptogenic brain insult.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172494.
    PubMed     Text format     Abstract available


  35. HEISS WD
    Hybrid MR/PET Imaging in Neurology: Present Applications and Prospects for the Future.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.175208.
    PubMed     Text format    


  36. JADVAR H
    SNMMI Leadership Update: Pathways to the Future of Nuclear Medicine.
    J Nucl Med. 2016;57:15N.
    PubMed     Text format    


    March 2016
  37. BINSE I, Poeppel TD, Ruhlmann M, Ezziddin S, et al
    68Ga-DOTATOC-PET/CT in patients with iodine- and 18F-FDG-negative differentiated thyroid carcinoma and elevated serum thyroglobulin.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171942.
    PubMed     Text format     Abstract available


  38. LEE HW, Lee HM, Choi SE, Yoo H, et al
    The Prognostic Impact of Early Change in Standardized Uptake Value of 18F-fluorodeoxy-glucose Positron Emission Tomography after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.166322.
    PubMed     Text format     Abstract available


  39. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine Part 2: A Report of the First Nuclear Medicine Global Initiative.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.169714.
    PubMed     Text format     Abstract available


  40. UNTERRAINER M, Schweisthal F, Suchorska B, Wenter V, et al
    Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma - does it make sense?
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171033.
    PubMed     Text format     Abstract available


  41. WAKABAYASHI H, Werner RA, Hayakawa N, Javadi MS, et al
    Initial Preclinical Evaluation of 18F-fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.
    J Nucl Med. 2016 Mar 24. pii: jnumed.116.172718.
    PubMed     Text format     Abstract available


  42. NIELSEN CH, Jeppesen TE, Kristensen LK, Jensen MM, et al
    PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-labeled Active Site Inhibited Factor VII.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.170266.
    PubMed     Text format     Abstract available


  43. JI T, Gao S, Liu Z, Xing H, et al
    99mTc-Glu-c(RGDyK)-bombesin SPECT Can Reduce Unnecessary Biopsy of BI-RADS Category 4 On Ultrasonography.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.168773.
    PubMed     Text format     Abstract available


  44. SEKINE T, Burgos N, Warnock G, Huellner MW, et al
    Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner- comparison with clinical single atlas- and CT-based attenuation correction.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.169045.
    PubMed     Text format     Abstract available


  45. YANG Y, Bec J, Zhou J, Zhang M, et al
    A high resolution prototype small-animal PET scanner dedicated to mouse brain imaging.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.165886.
    PubMed     Text format     Abstract available


  46. SIBILLE L, Chambert B, Alonso S, Barrau C, et al
    Impact of the Adaptive Statistical iterative Reconstruction (ASiR) technique on radiation dose and image quality in bone SPECT/CT.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.164772.
    PubMed     Text format     Abstract available


  47. PIERT M, Montgomery J, Kunju LP, Siddiqui J, et al
    18F-choline PET/MRI: the Additional Value of PET for MRI-guided Transrectal Prostate Biopsies.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170878.
    PubMed     Text format     Abstract available


  48. PINKER K, Riedl C, Ong L, Jochelson M, et al
    Impact of the number of lesions analyzed in metastatic breast cancer on response assessment by 18F-FDG PET/CT using PERCIST.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.166629.
    PubMed     Text format     Abstract available


  49. ZHU Y, Du R, Zhu Y, Shen Y, et al
    PET Mapping of Neurofunctional Changes in a Post-traumatic Stress Disorder Model.
    J Nucl Med. 2016 Mar 16. pii: jnumed.116.173443.
    PubMed     Text format     Abstract available


  50. KIM YI, Paeng JC, Cheon GJ, Suh KS, et al
    Prediction of Post-Transplantation Recurrence of Hepatocellular Carcinoma by Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170076.
    PubMed     Text format     Abstract available


  51. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171165.
    PubMed     Text format     Abstract available


  52. TIXIER F, Vriens D, Cheze-Le Rest C, Hatt M, et al
    Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in Non-Small Cell Lung Cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.166918.
    PubMed     Text format     Abstract available


  53. SORENSEN M, Munk OL, Oerntoft N, Frisch K, et al
    Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171579.
    PubMed     Text format     Abstract available


  54. HARKNESS BA, Fahey FH
    A Report on the Current State of Nuclear Medicine Physics Training: The Findings of the AAPM/SNMMI Joint Task Force.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171355.
    PubMed     Text format    


  55. ULANER GA, Goldman D, Gonen M, Pham H, et al
    Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.170456.
    PubMed     Text format     Abstract available


  56. UEDA S, Yoshizawa N, Shigekawa T, Takeuchi H, et al
    Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.167320.
    PubMed     Text format     Abstract available


  57. VAN WEEHAEGHE D, Ceccarini J, Delva A, Robberecht W, et al
    Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.166272.
    PubMed     Text format     Abstract available


  58. O'MALLEY J
    2015 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2016;57:13N-8N.
    PubMed     Text format    


    February 2016
  59. ZHU Y, Xu K, Xu C, Zhang J, et al
    PET Mapping for Brain-Computer-Interface-Based Stimulation in a Rat Model with Intracranial Electrode Implantation in the Ventro-posterior Medial Thalamus.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.171868.
    PubMed     Text format     Abstract available


  60. SONG IH, Lee TS, Park YS, Lee JS, et al
    Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.167155.
    PubMed     Text format     Abstract available


  61. RAUSCH I, Rust P, Difranco MD, Lassen M, et al
    Reproducibility of MRI Dixon-based attenuation correction in combined PET/MR with applications for lean body mass estimation.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168294.
    PubMed     Text format     Abstract available


  62. WIERTS R, Brans B, Havekes B, Kemerink G, et al
    Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168799.
    PubMed     Text format     Abstract available


  63. YU Y, Chan C, Ma T, Liu Y, et al
    Event-by-Event Continuous Respiratory Motion Correction for Dynamic PET Imaging.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.167676.
    PubMed     Text format     Abstract available


  64. CORNELIS F, Sotirchos V, Violari E, Sofocleous C, et al
    Fluoro-deoxyglucose PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.171926.
    PubMed     Text format     Abstract available


  65. BRENDEL M, Probst F, Jaworska A, Overhoff F, et al
    Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.167858.
    PubMed     Text format     Abstract available


  66. KRALL N, Pretto F, Mattarella M, Muller C, et al
    A technetium 99m-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.170514.
    PubMed     Text format     Abstract available


  67. RODRIGUEZ-VIEITEZ E, Carter SF, Chiotis K, Saint-Aubert L, et al
    Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.168732.
    PubMed     Text format     Abstract available


  68. ROWE CC, Jones G, Dore V, Pejoska S, et al
    Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.171595.
    PubMed     Text format     Abstract available


  69. LILJA JA, Thurfjell L, Sorensen J
    Visualization and Quantification of Three-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET using variable depth.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169169.
    PubMed     Text format     Abstract available


  70. LEE JH, Sato M, Coel MN, Lee KH, et al
    Prediction of PSA Progression in Castrate-Resistant Prostate Cancer based on Treatment-Associated Change in Tumor Burden Quantified by 18F-fluorocholine PET/CT.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169177.
    PubMed     Text format     Abstract available


  71. TSUKADA H, Kanazawa M, Ohba H, Nishiyama S, et al
    PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in Brain of Parkinson's Disease Model Monkey.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.169615.
    PubMed     Text format     Abstract available


  72. OHRI N, Duan F, Snyder BS, Wei B, et al
    Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.166934.
    PubMed     Text format     Abstract available


  73. TIAN M
    The Pathophysiologic Basis of Nuclear Medicine.
    J Nucl Med. 2016 Feb 9. pii: jnumed.116.173815.
    PubMed     Text format    


  74. HINDIE E, Zanotti-Fregonara P, Quinto M, Morgat C, et al
    Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    J Nucl Med. 2016 Feb 9. pii: jnumed.115.170423.
    PubMed     Text format     Abstract available


  75. NABULSI N, Mercier J, Holden D, Carre S, et al
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168179.
    PubMed     Text format     Abstract available


  76. PALYO R, Sinusas A, Liu YH
    High-Sensitivity and High-Resolution SPECT/CT Systems Provide Substantial Dose Reduction without Compromising Quantitative Precision for Assessment of Myocardial Perfusion or Function.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.164632.
    PubMed     Text format     Abstract available


  77. WARNDERS FJ, Waaijer SJ, Pool M, Lub-de Hooge MN, et al
    Biodistribution and PET Imaging of Labeled Bispecific T Cell Engaging Antibody targeting EpCAM.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168153.
    PubMed     Text format     Abstract available


  78. KOESTERS T, Friedman KP, Fenchel M, Zhan Y, et al
    Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.166967.
    PubMed     Text format     Abstract available


  79. SHEIKHBAHAEI S, Mena E, Marcus C, Wray R, et al
    18F-Fluorodeoxyglucose PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.165480.
    PubMed     Text format     Abstract available


  80. KENNY L
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
    J Nucl Med. 2016;57 Suppl 1:89S-95S.
    PubMed     Text format     Abstract available


  81. WAHL RL
    Quo Vadis: PET and Single-Photon Molecular Breast Imaging.
    J Nucl Med. 2016;57 Suppl 1:3S-8S.
    PubMed     Text format    


  82. AVRIL S, Muzic RF Jr, Plecha D, Traughber BJ, et al
    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:34S-9S.
    PubMed     Text format     Abstract available


  83. GROHEUX D, Cochet A, Humbert O, Alberini JL, et al
    18F-FDG PET/CT for Staging and Restaging of Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:17S-26S.
    PubMed     Text format     Abstract available


    January 2016
  84. LIU D DR, Khong PL, Gao Y, Mahmood U, et al
    Radiation Dosimetry of Whole-Body Dual Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.165944.
    PubMed     Text format     Abstract available


  85. BURGER IA, Casanova R, Steiger S, Husmann L, et al
    FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.167684.
    PubMed     Text format     Abstract available


  86. TEUHO J, Johansson J, Liden J, Hansen AE, et al
    Effect of attenuation correction to regional quantification between PET/MR and PET/CT: a multi-centre study using a three-dimensional brain phantom.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.166165.
    PubMed     Text format     Abstract available


  87. BOLLINENI VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen H, et al
    High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.170597.
    PubMed     Text format     Abstract available


  88. SU Y, Rubin B, McConathy J, Laforest R, et al
    Impact of MR based attenuation correction on neurological PET studies.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.164822.
    PubMed     Text format     Abstract available


  89. SEIBYL J, Catafau AM, Barthel H, Ishii K, et al
    Impact of training method on the robustness of the visual assessment of 18F-florbetaben PET scans: results from a Phase 3 trial.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.161927.
    PubMed     Text format     Abstract available


  90. APOLO AB, Lindenberg L, Shih JH, Mena E, et al
    Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166512.
    PubMed     Text format     Abstract available


  91. LUO Y, Pan Q, Shao Y, Yu M, et al
    Glucagon-like Peptide-1 Receptor PET/CT with 68Ga-NOTA-exendin-4 for Detecting Localized Insulinoma: a Prospective Cohort Study.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.167445.
    PubMed     Text format     Abstract available


  92. JONASSON M, Wall A, Chiotis K, Saint-Aubert L, et al
    Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.158519.
    PubMed     Text format     Abstract available


  93. O JH, Luber BS, Leal JP, Wang H, et al
    Response to early treatment evaluated with 18F-FDG PET and PERCIST 1.0 predicts survival in patients with Ewing sarcoma family of tumors treated with a monoclonal antibody to the insulin-like growth factor 1 receptor.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.162412.
    PubMed     Text format     Abstract available


  94. VAN ROSSUM PS, Fried DV, Zhang L, Hofstetter WL, et al
    The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.163766.
    PubMed     Text format     Abstract available


  95. LUEHMANN HP, Detering L, Fors BP, Pressly ED, et al
    PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166751.
    PubMed     Text format     Abstract available


  96. VAG T, Gerngross C, Herhaus P, Eiber M, et al
    First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161034.
    PubMed     Text format     Abstract available


  97. DEPPEN SA, Liu E, Blume JD, Clanton J, et al
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.163865.
    PubMed     Text format     Abstract available


  98. VILCHE MB, Reyes AL, Vasilskis E, Oliver P, et al
    68Ga-NOTA-UBI 29-41 as a PET tracer for detection of bacterial infection.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161265.
    PubMed     Text format     Abstract available


  99. JAKOBSEN S, Busk M, Jensen JB, Munk OL, et al
    A PET Tracer For Renal Organic Cation Transporters, 11C-metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.169292.
    PubMed     Text format     Abstract available


  100. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Comparative performance of 18F-FDG PET/MRI and 18F-FDG PET/CT regarding detection and characterization of pulmonary lesions in 121 oncologic patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.167486.
    PubMed     Text format     Abstract available


  101. KIM EE
    Nuclear Medicine and PET/CT Cases.
    J Nucl Med. 2016 Jan 7. pii: jnumed.116.172114.
    PubMed     Text format    


  102. SPICK C, Herrmann K, Czernin J
    18F-FDG PET/CT and PET/MRI perform equally well in cancer patients: Evidence from studies in more than 2300 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.158808.
    PubMed     Text format     Abstract available


  103. JADVAR H
    SNMMI Leadership Update: The Future of Nuclear Medicine.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  104. WALKER M, Ehrlichmann W, Stahlschmidt A, Pichler BJ, et al
    In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    J Nucl Med. 2016;57:115-21.
    PubMed     Text format     Abstract available


  105. TRIPATHI M, Tang CC, Feigin A, De Lucia I, et al
    Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
    J Nucl Med. 2016;57:60-6.
    PubMed     Text format     Abstract available


  106. LARSON SM
    EXINI Quantitative Bone Scan Index: Expanded Utility for the Planar Radionuclide Bone Scan.
    J Nucl Med. 2016;57:5-6.
    PubMed     Text format    


  107. URBAIN JL
    Coagulation Factor and Theranostics: A New Paradigm in Molecular Imaging.
    J Nucl Med. 2016;57:7-8.
    PubMed     Text format    


    December 2015
  108. DECAZES P, Metivier D, Rouquette A, Talbot JN, et al
    A method to improve the semi-quantification of 18F-fluorodeoxyglucose uptake : reliability of the estimated lean body mass using a limited field of acquisition, low dose CT from PET/CT.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.164913.
    PubMed     Text format     Abstract available


  109. SCHODER H, Zelenetz A, Hamlin P, Gavane S, et al
    Prospective Study of FLT PET for Early Interim Response Assessment in Advanced Stage B-cell Lymphoma.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.166769.
    PubMed     Text format     Abstract available


  110. GROHEUX D, Biard L, Giacchetti S, Teixeira L, et al
    18FDG-PET/CT for the early evaluation of response to neoadjuvant treatment in triple negative breast cancer: influence of the chemotherapy regimen.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163907.
    PubMed     Text format     Abstract available


  111. TAGO T, Furumoto S, Okamura N, Harada R, et al
    Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.166652.
    PubMed     Text format     Abstract available


  112. SCHACHT AC, Sorensen M, Munk OL, Frisch K, et al
    Radiosynthesis of novel N-11C-methyl-taurine conjugated bile acids and biodistribution studies in pigs by PET/CT.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.161711.
    PubMed     Text format     Abstract available


  113. OPREA-LAGER DE, Kramer G, van de Ven P, van den Eertwegh A, et al
    Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.167692.
    PubMed     Text format     Abstract available


  114. VIVASH LE, O'Brien TJ
    Imaging microglial activation with TSPO PET: Lighting up neurological diseases?
    J Nucl Med. 2015 Dec 23. pii: jnumed.114.141713.
    PubMed     Text format     Abstract available


  115. AN HJ, Seo S, Kang H, Choi H, et al
    MRI-Based Attenuation Correction for PET/MRI Using Multiphase Level-Set Method.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163550.
    PubMed     Text format     Abstract available


  116. GROGG K, Toole T, Ouyang J, Zhu X, et al
    NEMA and clinical evaluation of a novel brain PET-CT scanner.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.159723.
    PubMed     Text format     Abstract available


  117. KIM SJ, Cho YS, Moon SH, Bae JM, et al
    Primary Tumor FDG Avidity Affects the Performance of FDG PET/CT for Detecting Gastric Cancer Recurrence.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.163295.
    PubMed     Text format     Abstract available


  118. HOOGENDAM JP, Zweemer RP, Hobbelink MG, van den Bosch MA, et al
    99mTc-nanocolloid SPECT-MRI fusion for the selective assessment of non-enlarged sentinel lymph nodes in patients with early stage cervical cancer.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.164780.
    PubMed     Text format     Abstract available


  119. DIVINE MR, Katiyar P, Kohlhofer U, Quintanilla-Martinez L, et al
    A Population Based Gaussian Mixture Model Incorporating 18F-FDG-PET and DW-MRI Quantifies Tumor Tissue Classes.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.163972.
    PubMed     Text format     Abstract available


  120. IQBAL R, Kramer GM, Verwer EE, Huisman MC, et al
    Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166579.
    PubMed     Text format     Abstract available


  121. SCHOLTENS AM, Verberne HJ, Budde RP, Lam M, et al
    Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166884.
    PubMed     Text format     Abstract available


  122. MINAMIMOTO R, Hancock S, Schneider B, Chin F, et al
    Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.168393.
    PubMed     Text format     Abstract available


  123. FUKUSHIMA Y, Kumita SI, Tokita Y, Sato N, et al
    Prognostic value of myocardial perfusion SPECT following intravenous bolus administration of nicorandil in patients with acute ischemic heart failure.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.162420.
    PubMed     Text format     Abstract available


  124. DE SWART J, Chan HS, Goorden MC, Morgenstern A, et al
    Utilizing high-energy gamma photons for high-resolution 213Bi SPECT in mice.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.157685.
    PubMed     Text format     Abstract available


  125. ARULAPPU A, Battle M, Eisenblaetter M, McRobbie G, et al
    c-Met PET Imaging Detects Early Stage Loco-Regional Recurrence of Basal-Like Breast Cancer.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.164384.
    PubMed     Text format     Abstract available


  126. PRIOR JO, Peguret N, Pomoni A, Pappon M, et al
    Reduction of Respiratory Motion during PET/CT by Pulsatile-Flow Ventilation (PFV-PET/CT): A First Clinical Evaluation.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.163386.
    PubMed     Text format     Abstract available


  127. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Complementary, Selective PET-Imaging of Integrin Subtypes alpha5beta1 and alphavbeta3 Using Ga-68-Aquibeprin and Ga-68-Avebetrin.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165720.
    PubMed     Text format     Abstract available


  128. MACDONALD L, Hippe D, Bender L, Cotter E, et al
    Positron emission mammography image interpretation for reduced image count levels.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165787.
    PubMed     Text format     Abstract available


    November 2015
  129. AARNTZEN E, Hermsen R, Drenth J, Boerman O, et al
    Tc-99m-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165795.
    PubMed     Text format     Abstract available


  130. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    


  131. KIST JW, de Keizer B, van der Vlies M, Brouwers AH, et al
    124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer; results of a multicenter diagnostic cohort study (THYROPET).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168138.
    PubMed     Text format     Abstract available


  132. RUF J, von Wedel F, Furth C, Denecke T, et al
    Significance of a single time point hybrid-protocol for somatostatin receptor SPECT including multiphase CT in the diagnostic work-up of gastroenteoropancreatic neuroendocrine Neoplasms (GEP-NEN).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.161117.
    PubMed     Text format     Abstract available


  133. MICHL M, Lehner S, Paprottka PM, Ilhan H, et al
    PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165613.
    PubMed     Text format     Abstract available


  134. LOPEZ-RODRIGUEZ V, Galindo-Sarco C, Garcia-Perez FO, Ferro-Flores G, et al
    PET-Based Human Dosimetry of the Dimeric alphavbeta3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.161653.
    PubMed     Text format     Abstract available


  135. PYKA T, Weirich G, Einspieler I, Maurer T, et al
    [68Ga]PSMA-HBED PET for differential diagnosis of suspicious lung lesions in patients with prostate cancer.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164442.
    PubMed     Text format     Abstract available


  136. WATANABE S, Kato H, Shimosegawa E, Hatazawa J, et al
    Genetic and Environmental Influences on Regional Brain Uptake of 2-deoxy-2-[18F]fluoro-D-glucose: a PET Study in Monozygotic and Dizygotic Twins.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164004.
    PubMed     Text format     Abstract available


  137. TAHMASIAN M, Shao J, Meng C, Grimmer T, et al
    Based on the network degeneration hypothesis: separating individual patients with different neurodegenerative syndromes in a preliminary hybrid PET/MR study.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.165464.
    PubMed     Text format     Abstract available


  138. GRIMMER T, Wutz C, Alexopoulos P, Drzezga A, et al
    Visual versus fully-automated analyses of FDG- and Amyloid-PET for prediction of dementia due to Alzheimer's disease in mild cognitive impairment.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.163717.
    PubMed     Text format     Abstract available


  139. SHUKURI M, Mawatari A, Ohno M, Suzuki M, et al
    Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer's disease model mice.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.166116.
    PubMed     Text format     Abstract available


  140. JALLOW N, Christian PE, Sunderland J, Graham MM, et al
    Diagnostic Reference Levels of CT Radiation Dose in Oncology Whole-Body PET/CT.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160465.
    PubMed     Text format     Abstract available


  141. KIM EE
    Therapeutic Nuclear Medicine.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.169300.
    PubMed     Text format    


  142. JANSSEN I, Chen CC, Taieb D, Patronas NJ, et al
    68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared to other functional imaging modalities and CT/MRI.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161018.
    PubMed     Text format     Abstract available


  143. SPIELMANN V, Li WB, Zankl M, Oeh U, et al
    Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160713.
    PubMed     Text format     Abstract available


  144. KANAZAWA M, Ohba H, Harada N, Kakiuchi T, et al
    Evaluation of 6-11C-Methyl-m-tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with beta-11-L-DOPA and 18F-FDOPA in Parkinson's Disease Monkeys.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161802.
    PubMed     Text format     Abstract available


  145. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available


  146. LAFFON E, Burger IA, Lamare F, de Clermont-Gallerande H, et al
    SUVpeak performance in Lung Cancer: Comparison to Average SUV from 40 Hottest Voxels.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161968.
    PubMed     Text format     Abstract available


  147. CIVELEK AC
    New Insights: PET imaging to document synergistic therapy effect of the 'old'-ancient recipe, and the 'new'-modern drug in stroke.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166702.
    PubMed     Text format    


  148. LUO H, England CG, Graves SA, Sun H, et al
    PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-labeled Ramucirumab.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166462.
    PubMed     Text format     Abstract available


  149. RULLMANN M, Dukart J, Hoffmann KT, Luthardt J, et al
    Partial volume effect correction improves quantitative florbetaben beta-amyloid PET scan analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.161893.
    PubMed     Text format     Abstract available


  150. ZHOU H, Shen G, Zhang W, Cai H, et al
    18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy: a meta-analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.165407.
    PubMed     Text format     Abstract available


  151. HARADA R, Okamura N, Furumoto S, Furukawa K, et al
    18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.164848.
    PubMed     Text format     Abstract available


  152. PARKER JA
    From the ABNM: Practice of Nuclear Medicine.
    J Nucl Med. 2015;56:18N.
    PubMed     Text format    


  153. MAHMOOD U
    2015 SNMMI Highlights Lecture: Oncology, Part I.
    J Nucl Med. 2015;56:9N-16N.
    PubMed     Text format    


  154. JADVAR H
    SNMMI Leadership Update: Developing Evidence-Based Appropriate Use Criteria under the Protecting Access to Medicare Act of 2014.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  155. JERAJ R, Bradshaw T, Simoncic U
    Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy.
    J Nucl Med. 2015;56:1752-65.
    PubMed     Text format     Abstract available


  156. WAHL RL, Horner TJ, Lin TS, Kaminski MS, et al
    Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
    J Nucl Med. 2015;56:1800-3.
    PubMed     Text format     Abstract available


  157. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    J Nucl Med. 2015;56:1654-60.
    PubMed     Text format     Abstract available


  158. FROKLAGE FE, Boellaard R, Bakker E, Hendrikse NH, et al
    Quantification of 11C-Laniquidar Kinetics in the Brain.
    J Nucl Med. 2015;56:1730-5.
    PubMed     Text format     Abstract available


  159. DUBROFF JG, Doot RK, Falcone M, Schnoll RA, et al
    Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.
    J Nucl Med. 2015;56:1724-9.
    PubMed     Text format     Abstract available


    October 2015
  160. ZANOTTI-FREGONARA P, Xu R, Zoghbi SS, Liow JS, et al
    The positron emission tomographic radioligand 18F-FIMX images and quantifies metabotropic glutamate receptor 1 in proportion to the regional density of its gene transcript in human brain.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162461.
    PubMed     Text format     Abstract available


  161. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Evaluation of the outcome of lung nodules missed on 18F-FDG PET/MRI compared to 18F-FDG PET/CT in patients with known malignancies.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162966.
    PubMed     Text format     Abstract available


  162. RYLOVA SN, Del Pozzo L, Klingeberg C, Tonnesmann R, et al
    Immuno-PET imaging of CD30 positive lymphoma using 89Zr-DFO-AC-10.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162735.
    PubMed     Text format     Abstract available


  163. ZHANG H, Liu N, Gao S, Hu X, et al
    Can a Novel 18F-ALF-NOTA-PRGD2 PET/CT Predict the Treatment Sensitivity of Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.165514.
    PubMed     Text format     Abstract available


  164. SEKINE T, Buck A, Delso G, Ter Voert E, et al
    Evaluation of atlas-based attenuation correction for integrated PET/MR in human brain - application of a head atlas and comparison to true CT-based attenuation correction.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.159228.
    PubMed     Text format     Abstract available


  165. KURLAND BF, Muzi M, Peterson LM, Doot RK, et al
    Multicenter clinical trials using 18F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162289.
    PubMed     Text format     Abstract available


  166. BEIJST C, Kist JW, Elschot M, Viergever M, et al
    Quantitative comparison of I-124 PET/CT and I-131 SPECT/CT detectability.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162750.
    PubMed     Text format     Abstract available


  167. TORRADO-CARVAJAL A, Herraiz JL, Alcain E, Montemayor AS, et al
    Fast Patch-Based Pseudo-CT Synthesis from T1-Weighted MR Images for PET/MR Attenuation Correction in Brain Studies.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.156299.
    PubMed     Text format     Abstract available


  168. ROWE SP, Macura KJ, Ciarallo A, Mena E, et al
    Comparison of PSMA-based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.163782.
    PubMed     Text format     Abstract available


  169. AKLAN B, Oehmigen M, Beiderwellen K, Ruhlmann M, et al
    Impact of Point-Spread Function (PSF) Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.154757.
    PubMed     Text format     Abstract available


  170. HUELLNER MW, Barbosa FG, Husmann L, Pietsch CM, et al
    TNM staging of NSCLC: Comparison of PET/MR and PET/CT.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162040.
    PubMed     Text format     Abstract available


  171. SKOURA E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, et al
    The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumours: Experience from a national referral centre in the United Kingdom.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.166017.
    PubMed     Text format     Abstract available


  172. CHAE SY, Choi CM, Shim TS, Park Y, et al
    Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate Positron Emission Tomography of Inflammatory and Infectious Lesions.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.164020.
    PubMed     Text format     Abstract available


  173. LJUNGBERG M, Celler A, Konijnenberg MW, Eckerman KF, et al
    MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.159012.
    PubMed     Text format     Abstract available


  174. RUBEAUX M, Joshi N, Dweck MR, Fletcher A, et al
    Motion correction of 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162990.
    PubMed     Text format     Abstract available


  175. KLENK C, Gawande R, Tran VT, Trinh J, et al
    Progressing towards a cohesive pediatric 18F-FDG PET/MR protocol: Is the administration of Gadolinium-Chelates necessary?
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.161646.
    PubMed     Text format     Abstract available


  176. ZHANG J, Li D, Lang L, Zhu Z, et al
    68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.165316.
    PubMed     Text format     Abstract available


  177. KEYAERTS M, Xavier C, Heemskerk J, Devoogdt N, et al
    Phase I study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2-expression in breast carcinoma.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162024.
    PubMed     Text format     Abstract available


  178. KRIZSAN AK, Lajtos I, Dahlbom M, Daver F, et al
    Promising future: Comparable Imaging Capability of MRI compatible SiPM and Conventional Photo-sensor Based Preclinical PET Systems.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.157677.
    PubMed     Text format     Abstract available


  179. BAGUNA TORRES J, Andreozzi E, Dunn J, Siddique M, et al
    PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162370.
    PubMed     Text format     Abstract available


  180. ZHENG K, Liang N, Zhang J, Lang L, et al
    68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.160648.
    PubMed     Text format     Abstract available


  181. KIM EE
    Molecular Anatomic Imaging: PET/CT, PET/MR and SPECT/CT, third edition.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.167130.
    PubMed     Text format    


  182. GUNGOR H, Saleem A, Babar S, Dina R, et al
    Dose-finding quantitative FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecological malignancies.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.156505.
    PubMed     Text format     Abstract available


  183. CZERNIN J
    Reply: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.166181.
    PubMed     Text format    


  184. OSBORNE JR, Beylergil V, Sammit C, Graham MM, et al
    Letter: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.165621.
    PubMed     Text format    


  185. WEBER WA, Gatsonis C, Siegel B
    Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1636.
    PubMed     Text format    


  186. VAN DEN HOFF J, Hofheinz F
    Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1635-6.
    PubMed     Text format    


  187. BOHNEN NI
    2015 SNMMI Highlights Lecture: Neurosciences.
    J Nucl Med. 2015;56:13N-20N.
    PubMed     Text format    


  188. COLLAMATI F, Bellini F, Bocci V, De Lucia E, et al
    Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with beta- Decay.
    J Nucl Med. 2015;56:1501-6.
    PubMed     Text format     Abstract available


  189. OLIVEIRA BL, Blasi F, Rietz TA, Rotile NJ, et al
    Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
    J Nucl Med. 2015;56:1587-92.
    PubMed     Text format     Abstract available


  190. SELIVANOVA SV, Lavallee E, Senta H, Caouette L, et al
    Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    J Nucl Med. 2015;56:1600-8.
    PubMed     Text format     Abstract available


    September 2015
  191. DE LAAT B, Leurquin-Sterk G, Celen S, Bormans G, et al
    Preclinical evaluation and quantification of 18F-FPEB as a radioligand for PET imaging of the metabotropic glutamate receptor 5.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162636.
    PubMed     Text format     Abstract available


  192. SLOMKA PJ PHD, Rubeaux M PhD, Le Meunier L PhD, Dey D PhD, et al
    Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F18.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.164285.
    PubMed     Text format     Abstract available


  193. HARTENBACH M, Weber S, Albert NL, Hartenbach S, et al
    Evaluating treatment response of radioembolization in intermediate stage hepatocellular carcinoma patients using 18Fluoroethylcholine-PET/CT.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.158758.
    PubMed     Text format     Abstract available


  194. AMBROSINI V, Campana D, Polverari G, Peterle C, et al
    Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162719.
    PubMed     Text format     Abstract available


  195. MINAMIMOTO R, Loening A, Jamali M, Barkhodari A, et al
    Prospective Comparison of 99mTc MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT and Whole-Body MRI in Patients with Breast and Prostate Cancers.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162610.
    PubMed     Text format     Abstract available


  196. INCERTI E, Fodor A, Mapelli P, Fiorino C, et al
    Radiation treatment of lymph node recurrence from prostate cancer: is 11C-choline PET/CT predictive of survival outcomes?
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.163741.
    PubMed     Text format     Abstract available


  197. ALESSIO AM, Farrell MB, Fahey FH
    Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.160861.
    PubMed     Text format    


  198. SHARMA R, Kallur K, Ryu J, Parameswaran R, et al
    Multi-Centre Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.158253.
    PubMed     Text format     Abstract available


  199. PARKER CA, Rabiner EI, Gunn R, Searle G, et al
    Human kinetic modelling of the 5-HT6 PET radioligand, 11C-GSK215083, and its utility for determining occupancy at both 5HT6 and 5HT2A receptors by SB742457 as a potential therapeutic mechanism of action in Alzheimer's disease.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.162743.
    PubMed     Text format     Abstract available


  200. VAN DER VOS CS, Grootjans W, Osborne DR, Meeuwis AP, et al
    Improving the spatial alignment in PET/CT using amplitude-based respiratory gated PET and respiratory triggered CT.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.163055.
    PubMed     Text format     Abstract available


  201. NIELSEN CH, Erlandsson M, Jeppesen TE, Jensen MM, et al
    Quantitative PET Imaging of Tissue Factor Expression Using 18F-labled Active Site Inhibited Factor VII.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.154849.
    PubMed     Text format     Abstract available


  202. UMEDA Y, Demura Y, Morikawa M, Anzai M, et al
    Prognostic value of dual-time-point [18F]-2-fluoro-2-deoxyglucose PET for idiopathic pulmonary fibrosis.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163360.
    PubMed     Text format     Abstract available


  203. HOSOKAWA C, Ishii K, Kimura Y, Hyodo T, et al
    Performance of 11C-PiB PET binding potential images in the equivocal static images in the detection of amyloid deposits.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.156414.
    PubMed     Text format     Abstract available


  204. BLANCHET E, Taieb D, Millo C, Martucci V, et al
    18F-FLT PET/CT in the evaluation of pheochromocytomas and paragangliomas: A pilot study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.159061.
    PubMed     Text format     Abstract available


  205. KANZAKI Y, Yamauchi Y, Morita H, Hayashi M, et al
    Presence of Post-systolic Shortening Increases the Likelihood of Coronary Artery Disease: A Rest ECG-gated Myocardial Perfusion SPECT Study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.153791.
    PubMed     Text format     Abstract available


  206. ZHANG H, Song F, Xu C, Liu H, et al
    Spatiotemporal PET imaging of dynamic metabolic changes after combined therapeutic approach of induced pluripotent stem cells (iPSCs), neuronal stem cells (NSCs) and Chinese patent medicine in a rat model of cerebral ischemic-reperfusion injury.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163170.
    PubMed     Text format     Abstract available


  207. KOSTAKOGLU L, Duan F, Idowu MO, Jolles PR, et al
    A Phase II Study of [(18)F]-3'Deoxy-3'-Fluorothymidine Positron Emission Tomography (FLT-PET) in The Asessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results From ACRIN 6688.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.160663.
    PubMed     Text format     Abstract available


  208. TRAXL A, Wanek T, Mairinger S, Stanek J, et al
    Breast Cancer Resistance Protein and P-glycoprotein Influence In Vivo Disposition of 11C-Erlotinib.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.161273.
    PubMed     Text format     Abstract available


  209. GUTTE H, Hansen AE, Larsen M, Rahbek S, et al
    Simultaneous hyperpolarized 13C-pyruvate MRI and 18F-FDG-PET (hyperPET) in 10 canine cancer patients.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.156364.
    PubMed     Text format     Abstract available


  210. JOSHI AD, Pontecorvo MJ, Skovronsky DM, Mintun MA, et al
    A semi-automated method for quantification of florbetapir F 18 PET images.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.153494.
    PubMed     Text format     Abstract available


  211. BEN BOUALLEGUE F, Roubille F, Lattuca B, Cung TT, et al
    SPECT Myocardial Perfusion Reserve in Patients with Multivessel Coronary Disease: Correlation with Angiographic Findings and Invasive Fractional Flow Reserve Measurements.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.143164.
    PubMed     Text format     Abstract available


  212. LE ROUX PY, Siva S, Steinfort DP, Callahan J, et al
    Correlation of 68Gallium ventilation-perfusion PET/CT with pulmonary function test indices for assessing lung function.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.162586.
    PubMed     Text format     Abstract available


  213. GORDON L, Metter D, Elman S
    Women in Nuclear Medicine.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  214. SEGALL G
    Nuclear Medicine, Social Media, and Two Degrees of Separation.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  215. FREY KA
    Reply: Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1467.
    PubMed     Text format    


  216. MACHULLA HJ
    Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1466-7.
    PubMed     Text format    


  217. DILSIZIAN V
    2015 SNMMI Highlights Lecture: Cardiovascular Nuclear and Molecular Imaging.
    J Nucl Med. 2015;56:13N-9N.
    PubMed     Text format    


  218. KING MT, Carpenter CM, Sun C, Ma X, et al
    beta-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
    J Nucl Med. 2015;56:1458-64.
    PubMed     Text format     Abstract available


  219. ZIMMERMAN BE, Bergeron DE, Cessna JT
    Impact of Recent Change in the National Institute of Standards and Technology Standard for 18F on the Relative Response of 68Ge-Based Mock Syringe Dose Calibrator Standards.
    J Nucl Med. 2015;56:1453-7.
    PubMed     Text format     Abstract available


  220. VAN DUIJNHOVEN SM, Rossin R, van den Bosch SM, Wheatcroft MP, et al
    Diabody Pretargeting with Click Chemistry In Vivo.
    J Nucl Med. 2015;56:1422-8.
    PubMed     Text format     Abstract available


  221. MAURER AH
    Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.
    J Nucl Med. 2015;56:1395-400.
    PubMed     Text format     Abstract available


  222. KEIDING S
    How Should Lumped Constant Be Estimated for Hepatic 18F-FDG Glucose in Humans?
    J Nucl Med. 2015;56:1302-3.
    PubMed     Text format    


  223. MACHULLA HJ
    Imaging of Apoptosis: The Need to Distinguish Tracer Uptake Rate from Regional Contribution of Blood Flow.
    J Nucl Med. 2015;56:1300-1.
    PubMed     Text format    


    August 2015
  224. JACOBSON O, Weiss I, Wang L, Wang Z, et al
    18F-labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160960.
    PubMed     Text format     Abstract available


  225. RENDON DA, Kotedia K, Afshar SF, Punia JN, et al
    Mapping radiation injury and recovery in bone marrow using 18F-FLT PET/CT and USPIO-MR imaging in a rat model.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.158121.
    PubMed     Text format     Abstract available


  226. GEWIRTZ H
    SPECT MPI: Post stress, end systolic images and the ongoing effort to improve diagnostic accuracy.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.164111.
    PubMed     Text format    


  227. BURT T, Rouse D, Lee K, Wu H, et al
    Intra-Arterial Microdosing (IAM): A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160986.
    PubMed     Text format     Abstract available


  228. ANAND A, Morris MJ, Kaboteh R, Bath L, et al
    Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160085.
    PubMed     Text format     Abstract available


  229. CHOI H, Lee DS
    PET and SPECT of Neurobiological Systems.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164616.
    PubMed     Text format    


  230. FINK J, Muzi M, Peck M, Krohn KA, et al
    Multi-modality Brain Tumor Imaging - MRI, PET, and PET/MRI.
    J Nucl Med. 2015 Aug 20. pii: jnumed.113.131516.
    PubMed     Text format     Abstract available


  231. CHOI H, Lee DS
    PET and SPECT in Psychiatry.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164608.
    PubMed     Text format    


  232. IAGARU AH
    18F NaF PET in the Assessment of Malignant Bone Disease.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.162784.
    PubMed     Text format    


  233. AFSHAR-OROMIEH A, Hetzheim H, Kratochwil C, Benesova M, et al
    The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161299.
    PubMed     Text format     Abstract available


  234. BUVAT I, Orhlac F, Soussan M
    Tumor texture analysis in PET: where do we stand?
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.163469.
    PubMed     Text format    


  235. PARSONS M, Goldman D, Dashevsky B, Riedl CC, et al
    Value of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Breast Cancer (ILC) as Compared with Invasive Ductal Breast Cancer (IDC).
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161455.
    PubMed     Text format     Abstract available


  236. STENDAHL J, Sinusas AJ
    Nanoparticles for cardiovascular imaging and therapeutic delivery, Part 2: Radiolabeled probes.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164145.
    PubMed     Text format     Abstract available


  237. FRANZ D, Karampinos DC, Rummeny EJ, Souvatzoglou M, et al
    Discrimination between brown and white adipose tissue using a two-point Dixon water-fat separation method in simultaneous PET/MRI.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.160770.
    PubMed     Text format     Abstract available


  238. KITKUNGVAN D MD, Vejpongsa P Md, Korrane K Md, Sdringola S Md, et al
    Clinical Utility of Enhanced Relative Activity Recovery on Systolic Myocardial Perfusion SPECT - Lessons from PET.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.153759.
    PubMed     Text format     Abstract available


  239. LEE DS
    Introduction to book series review: 'PET and SPECT in Neurology, PET and SPECT in Psychiatry, and PET and SPECT of Neurobiological Systems'.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164582.
    PubMed     Text format    


  240. KIM YK, Lee DS
    PET and SPECT in Neurology.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164590.
    PubMed     Text format    


  241. BAUMAN A, Valverde IE, Fischer CA, Vomstein S, et al
    Development of Gallium-68 and Zirconium-89 Labelled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159186.
    PubMed     Text format     Abstract available


  242. MAIER FC, Keller MD, Bukala D, Bender B, et al
    Quantification of beta-amyloidosis and rCBF with dedicated PET, 7 T-MR imaging and high-resolution microscopic MR imaging at 16.4 T in APP23 mice.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159350.
    PubMed     Text format     Abstract available


  243. ZHANG J, Lang L, Li F, Zhu Z, et al
    Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159640.
    PubMed     Text format     Abstract available


  244. TASWELL C, Villemagne VL, Yates P, Shimada H, et al
    FDG-PET improves diagnosis in patients presenting with focal onset dementias.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.161067.
    PubMed     Text format     Abstract available


  245. LEE JW, Jo K, Cho A, Noh SH, et al
    Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.160580.
    PubMed     Text format     Abstract available



  246. SNMMI 2015 Image of the Year.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  247. ZUBAL G
    From the Exhibitors' Hall: SNMMI Annual Meeting 2015.
    J Nucl Med. 2015;56:16N-19N.
    PubMed     Text format    


  248. HU K, Wang H, Tang G, Huang T, et al
    In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots.
    J Nucl Med. 2015;56:1278-84.
    PubMed     Text format     Abstract available


  249. MUZI M, Peterson LM, O'Sullivan JN, Fink JR, et al
    18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    J Nucl Med. 2015;56:1223-8.
    PubMed     Text format     Abstract available


  250. BUTOF R, Hofheinz F, Zophel K, Stadelmann T, et al
    Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    J Nucl Med. 2015;56:1150-6.
    PubMed     Text format     Abstract available


  251. WEINEISEN M, Schottelius M, Simecek J, Baum RP, et al
    68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    J Nucl Med. 2015;56:1169-76.
    PubMed     Text format     Abstract available


  252. MAURER AH
    Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying.
    J Nucl Med. 2015;56:1229-38.
    PubMed     Text format     Abstract available


  253. NERI D
    Imaging T Cells In Vivo.
    J Nucl Med. 2015;56:1135-6.
    PubMed     Text format    


  254. TAVARE R, McCracken MN, Zettlitz KA, Salazar FB, et al
    Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
    J Nucl Med. 2015;56:1258-64.
    PubMed     Text format     Abstract available


    July 2015
  255. JIMENEZ-HEFFERNAN A, Ellman A, Sado HN, Huic D, et al
    Results of a prospective International Atomic Energy Ahency (IAEA) sentinel node trial on the value of SPECT/CT over planar imaging in various malignancies.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.153643.
    PubMed     Text format     Abstract available


  256. BRUNKEN RC
    Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.161661.
    PubMed     Text format    


  257. YAN J, Lim JC, Loi HY, Khor LK, et al
    Impact of image reconstruction settings on Texture Features in 18F-FDG PET.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.156927.
    PubMed     Text format     Abstract available


  258. HALLE B, Thisgaard H, Hvidsten S, Dam JH, et al
    Estimation of Tumor Volumes by [11C]MeAIB and [18F]FDG PET in an Orthotopic Glioblastoma Rat Model.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.162511.
    PubMed     Text format     Abstract available


  259. PAEZ D, Orellana P, Gutierrez C, Ramirez R, et al
    Current Status of Nuclear Medicine Practice in Latin America and the Caribbean.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.148932.
    PubMed     Text format     Abstract available


  260. GHEYSENS O, Postnov A, Deroose CM, Vandermeulen C, et al
    Quantification, Variability and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Lean Healthy Humans using 18F-FDG-PET/CT.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159715.
    PubMed     Text format     Abstract available


  261. HELLWIG S, Frings L, Amtage F, Buchert R, et al
    18F-FDG PET is an early predictor of overall survival in suspected atypical parkinsonism.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159822.
    PubMed     Text format     Abstract available


  262. WAWRZYNIAK AJ, Dilsizian V, Krantz DS, Harris KM, et al
    High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.157990.
    PubMed     Text format     Abstract available


  263. LAU J, Liu Z, Lin KS, Pan J, et al
    Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging.
    J Nucl Med. 2015 Jul 23. pii: jnumed.114.153288.
    PubMed     Text format     Abstract available


  264. AYRES KL, Spottswood SE, Delbeke D, Price RR, et al
    Dose Optimization in Pediatric Bone Scintigraphy: Validation of the 2010 North American Consensus Guidelines.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.156141.
    PubMed     Text format     Abstract available


  265. SHURYAK I, Dadachova E
    New Approaches for Modeling Radiopharmaceutical Pharmacokinetics Using Continuous Distributions of Rates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.160515.
    PubMed     Text format     Abstract available


  266. JENSEN P, Feng L, Law I, Svarer C, et al
    TSPO imaging in glioblastoma multiforme: A direct comparison between 123ICLINDE-SPECT, 18F-FET PET and gadolinium-enhanced MRI.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158998.
    PubMed     Text format     Abstract available


  267. GRECCHI E, O' Doherty J, Veronese M, Tsoumpas C, et al
    Multimodal Partial Volume Correction - Application to 18F-Fluoride PET/CT bone metastases studies.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160598.
    PubMed     Text format     Abstract available


  268. WERNER RA, Rischpler C, Onthank D, Lapa C, et al
    Retention Kinetics of the 18F-labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-HED and 123I-MIBG.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158493.
    PubMed     Text format     Abstract available


  269. KIESS A, Minn I, Chen Y, Hobbs RF, et al
    Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.155929.
    PubMed     Text format     Abstract available


  270. KIMURA Y, Ichise M, Ito H, Shimada H, et al
    PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160127.
    PubMed     Text format     Abstract available


  271. PAN Q, Li J, Li F, Zhou D, et al
    Characterizing POEMS syndrome with 18F-Fludeoxyglucose positron emission tomography/computed tomography.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160507.
    PubMed     Text format     Abstract available


  272. BYRNE K, Siva S, Chait L, Callahan J, et al
    15-year Experience of 18F-FDG PET Imaging in Response Assessment and Re-staging after Definitive Treatment of Merkel Cell Carcinoma.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158261.
    PubMed     Text format     Abstract available


  273. TRAGARDH M, Moller N, Sorensen M
    Methodological Considerations when Performing Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.154211.
    PubMed     Text format     Abstract available


  274. NGUYEN NC, Vercher-Conejero JL, Sattar A, Miller M, et al
    Image quality and diagnostic performance of a digital PET prototype in patients with oncologic diseases: Initial experience and comparison with analog PET.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.148338.
    PubMed     Text format     Abstract available


  275. CHAMPION L, Lerebours F, Alberini JL, Fourme E, et al
    18F-FDG PET/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158287.
    PubMed     Text format     Abstract available


  276. TEOH EJ, McGowan DR, Macpherson RE, Bradley KM, et al
    Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.159301.
    PubMed     Text format     Abstract available


  277. BRODOV Y, Gransar H, Dey D, Shalev A, et al
    Combined Quantitative Assessment of Myocardial Perfusion and Coronary Artery Calcium Score by Hybrid 82Rb PET/CT Improves Detection of Coronary Artery Disease.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.153429.
    PubMed     Text format     Abstract available


  278. MANSOR MS, Boellaard R, Froklage FE, Bakker ED, et al
    Quantification of dynamic 11C-Phenytoin PET studies.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158055.
    PubMed     Text format     Abstract available


  279. DEN HOLLANDER MW, Bensch F, Glaudemans AW, Oude Munnink TH, et al
    TGF-beta antibody uptake in recurrent high grade glioma imaged with 89Zr-fresolimumab PET.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.154401.
    PubMed     Text format     Abstract available


  280. ROHREN EM, Etchebehere E, Araujo J, Hobbs BP, et al
    DETERMINATION OF SKELETAL TUMOR BURDEN ON 18F-FLUORIDE PET/CT.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156026.
    PubMed     Text format     Abstract available


  281. SODERLUND TA, Chaal J, Tjio G, Totman JJ, et al
    Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application - 18F, 11C, 89Zr, 124I, 68Ga and 90Y.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156711.
    PubMed     Text format     Abstract available


  282. KAWADA K, Toda K, Nakamoto Y, Iwamoto M, et al
    Relationship between FDG-PET/CT scans and KRAS Mutations in Metastatic Colorectal Cancer.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.160614.
    PubMed     Text format     Abstract available


  283. CARBONELL F, Zijdenbos AP, Charil A, Grand'Maison M, et al
    Optimal Target Region for Subject Classification based on Amyloid PET Images.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158774.
    PubMed     Text format     Abstract available


  284. MOROZ MA, Zhang H, Lee J, Moroz E, et al
    Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.
    J Nucl Med. 2015;56:1055-60.
    PubMed     Text format     Abstract available


  285. LAVISSE S, Garcia-Lorenzo D, Peyronneau MA, Bodini B, et al
    Optimized Quantification of Translocator Protein Radioligand (1)(8)F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    J Nucl Med. 2015;56:1048-54.
    PubMed     Text format     Abstract available


  286. STRAUSS HW, Narula J, Nakahara T
    Finding Calcium in Noncalcified Lesions: (1)(8)F-Fluoride Offers Insights into Atheroma Evolution.
    J Nucl Med. 2015;56:974-5.
    PubMed     Text format    


  287. FAHEY F, Zukotynski K, Jadvar H, Capala J, et al
    Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
    J Nucl Med. 2015;56:1119-29.
    PubMed     Text format    


  288. MENDLER CT, Gehring T, Wester HJ, Schwaiger M, et al
    (8)(9)Zr-Labeled Versus (1)(2)(4)I-Labeled alphaHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    J Nucl Med. 2015;56:1112-8.
    PubMed     Text format     Abstract available


  289. SOJKOVA J, Goh J, Bilgel M, Landman B, et al
    Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of beta-Amyloid Images.
    J Nucl Med. 2015;56:1042-7.
    PubMed     Text format     Abstract available


  290. BRAAT AJ, Smits ML, Braat MN, van den Hoven AF, et al
    (9)(0)Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.
    J Nucl Med. 2015;56:1079-87.
    PubMed     Text format     Abstract available


  291. JOUTSA J, Johansson J, Seppanen M, Noponen T, et al
    Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease.
    J Nucl Med. 2015;56:1036-41.
    PubMed     Text format     Abstract available


  292. LE ROUX PY, Pelletier-Galarneau M, de Laroche R, Hofman MS, et al
    Pulmonary scintigraphy for the diagnosis of acute pulmonary embolism: a survey of current practices in Australia, Canada and France.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.157743.
    PubMed     Text format     Abstract available


    June 2015
  293. PENG F, Muzik O, Gatson J, Kernie S, et al
    Detection of Increased 64Cu uptake in Traumatic Brain Injury with 64CuCl2-PET/CT.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.154575.
    PubMed     Text format     Abstract available


  294. MORIGI JJ, Stricker P, Van Leeuwen P, Tang R, et al
    Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.160382.
    PubMed     Text format     Abstract available


  295. PEREZ-MEDINA C, Tang J, Abdel-Atti D, Hogstad B, et al
    PET Imaging of Tumor-Associated Macrophages with 89Zr-labeled HDL Nanoparticles.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.158956.
    PubMed     Text format     Abstract available


  296. ULANER GA, Riedl C
    Reply: Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.161042.
    PubMed     Text format    


  297. KINAHAN PE, Mankoff D, Linden H
    The value of establishing the quantitative accuracy of PET/CT imaging.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.159178.
    PubMed     Text format    


  298. GATES VL, Singh N, Lewandowski R, Spies SM, et al
    INTRA-ARTERIAL HEPATIC SPECT/CT IMAGING USING TECHNETIUM-99M MACRO-AGGREGATED ALBUMIN IN PREPARATION FOR RADIOEMBOLIZATION.
    J Nucl Med. 2015 Jun 18. pii: jnumed.114.153346.
    PubMed     Text format     Abstract available


  299. ZANOTTI-FREGONARA P, Laforest R, Wallis JW
    Fetal radiation dose from [18F]-FDG in pregnant patients imaged with PET, PET/CT and PET/MRI.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.157032.
    PubMed     Text format     Abstract available


  300. LUBBERINK M, Golla SS, Jonasson M, Rubin K, et al
    The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
    J Nucl Med. 2015 Jun 11. pii: jnumed.114.151894.
    PubMed     Text format     Abstract available


  301. ETCHEBEHERE E, Araujo JC, Fox PS, Swanston NM, et al
    Prognostic factors in patients treated with radium-223: the role of skeletal tumor burden on baseline 18F-fluoride-PET/CT in predicting overall survival.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.158626.
    PubMed     Text format     Abstract available


  302. BLYKERS A, Schoonooghe S, Xavier C, D'hoe K, et al
    PET imaging of MMR-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156828.
    PubMed     Text format     Abstract available


  303. ROWE SP, Gage KL, Faraj SF, Macura K, et al
    18F-DCFBC PET/CT for PSMA-based Detection and Characterization of Primary Prostate Cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.154336.
    PubMed     Text format     Abstract available


  304. KIM DY, Kim HS, Reder S, Zheng JH, et al
    Comparison of 18F-labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156794.
    PubMed     Text format     Abstract available


  305. HEIDARI P, Esfahani S, Turker NS, Wong G, et al
    Imaging of the secreted extracellular periostin, an important marker of invasion in tumor microenvironment in esophageal cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156216.
    PubMed     Text format     Abstract available


  306. KAUHANEN S, Rinta-Kiikka I, Kemppainen J, Gronroos J, et al
    The diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT), multidetector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the diagnosis of pancreatic cysts; a prospectiv
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.148940.
    PubMed     Text format     Abstract available


  307. HIRATA K, Hattori N, Takeuchi W, Shiga T, et al
    Metabolic activity of red nucleus and its correlation with cerebral cortex and cerebellum - a study using a high-resolution semiconductor PET system.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152504.
    PubMed     Text format     Abstract available


  308. HUSBY JA, Reitan BC, Biermann M, Trovik J, et al
    Metabolic tumor volume (MTV) at 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG-PET/CT) improves preoperative identification of high-risk endometrial carcinoma patients.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.159913.
    PubMed     Text format     Abstract available


  309. GROHEUX D, Hindie E
    Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.160945.
    PubMed     Text format    


  310. CHEN YJ, Rosario BL, Mowrey W, Laymon CM, et al
    PiB Relative Delivery (R1) as a Proxy of Relative Cerebral Blood Flow: Quantitative Evaluation Using Single Session 15O-Water and 11C-PiB PET.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152405.
    PubMed     Text format     Abstract available


  311. PALNER M, Shen B, Jeon J, Lin J, et al
    Preclinical kinetic analysis of the Caspase-3/7 PET tracer 18F-C-SNAT for imaging tumor apoptosis after chemotherapeutic treatment.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.155259.
    PubMed     Text format     Abstract available


  312. DIMITRIU-LEEN AC, Scholte AJ, Jacobson AF
    123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:25S-30S.
    PubMed     Text format     Abstract available


  313. HAROLDS JA, Oates ME, Guiberteau MJ, Ghesani M, et al
    New training pathways to dual certification in nuclear medicine and radiology.
    J Nucl Med. 2015;56:17N-8N.
    PubMed     Text format    


  314. GARIN E, Edeline J
    Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:969.
    PubMed     Text format    


  315. HOFMAN MS, Michael M, Kashyap R, Hicks RJ, et al
    Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:968-9.
    PubMed     Text format    


  316. BORGQUIST R, Singh JP
    An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help?
    J Nucl Med. 2015;56 Suppl 4:59S-64S.
    PubMed     Text format     Abstract available


  317. ABDULGHANI M, Duell J, Smith M, Chen W, et al
    Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123I-MIBG.
    J Nucl Med. 2015;56 Suppl 4:52S-58S.
    PubMed     Text format     Abstract available


  318. LEVINE A, Hecht HS
    Cardiac CT Angiography in Congestive Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:46S-51S.
    PubMed     Text format     Abstract available


  319. JACOBSON AF, Narula J
    Introduction to cardiac neuronal imaging: a clinical perspective.
    J Nucl Med. 2015;56 Suppl 4:3S-6S.
    PubMed     Text format     Abstract available


  320. NAKAJIMA K, Nakata T
    Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    J Nucl Med. 2015;56 Suppl 4:11S-19S.
    PubMed     Text format     Abstract available



  321. Deadlines for Appropriate Use Criteria loom; resolutions remain unclear.
    J Nucl Med. 2015;56:23N-24N.
    PubMed     Text format    


  322. SEGALL G
    ABNM Maintenance of Certification: Getting It Right.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  323. DHAWAN V, Robeson W, Bjelke D, Chaly T, et al
    Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
    J Nucl Med. 2015;56:869-72.
    PubMed     Text format     Abstract available


  324. FAHEY FH, Ziniel SI, Manion D, Treves ST, et al
    Effects of Image Gently and the North American guidelines: administered activities in children at 13 North American pediatric hospitals.
    J Nucl Med. 2015;56:962-7.
    PubMed     Text format     Abstract available


  325. MONCAYO VM, Aarsvold JN, Alazraki NP
    Lymphoscintigraphy and sentinel nodes.
    J Nucl Med. 2015;56:901-7.
    PubMed     Text format     Abstract available


  326. PRINCE JF, van Rooij R, Bol GH, de Jong HW, et al
    Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    J Nucl Med. 2015;56:817-23.
    PubMed     Text format     Abstract available


  327. JIANG L, Tu Y, Kimura RH, Habte F, et al
    64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    J Nucl Med. 2015;56:939-44.
    PubMed     Text format     Abstract available


  328. JUNG JJ, Razavian M, Challa AA, Nie L, et al
    Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    J Nucl Med. 2015;56:933-8.
    PubMed     Text format     Abstract available


  329. HERRMANN K, Bluemel C, Weineisen M, Schottelius M, et al
    Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
    J Nucl Med. 2015;56:855-61.
    PubMed     Text format     Abstract available


  330. VAN BERKEL A, Rao JU, Lenders JW, Pellegata NS, et al
    Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    J Nucl Med. 2015;56:839-46.
    PubMed     Text format     Abstract available


  331. PELLETIER-GALARNEAU M, Sogbein OO, Pham X, Hao J, et al
    Multicenter validation of a shortened gastric-emptying protocol.
    J Nucl Med. 2015;56:873-6.
    PubMed     Text format     Abstract available


  332. LIN C, Kume K, Mori T, Martinez ME, et al
    Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
    J Nucl Med. 2015;56:945-50.
    PubMed     Text format     Abstract available


    May 2015
  333. PAULUS DH, Quick HH, Geppert C, Fenchel M, et al
    Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone.
    J Nucl Med. 2015 May 29. pii: jnumed.115.156000.
    PubMed     Text format     Abstract available


  334. ANTWI K, Fani M, Nicolas G, Rottenburger C, et al
    Localization of hidden Insulinomas with 68Ga-DOTA-exendin-4 PET/CT: A Pilot Study.
    J Nucl Med. 2015 May 21. pii: jnumed.115.157768.
    PubMed     Text format     Abstract available


  335. ROWE SP, Vicente E, Anizan N, Wang H, et al
    Repeatability of radiotracer uptake in normal abdominal organs with 111In-pentetreotide quantitative SPECT/CT.
    J Nucl Med. 2015 May 14. pii: jnumed.115.155358.
    PubMed     Text format     Abstract available


  336. HWANG H, Jeong HS, Oh PS, Na KS, et al
    Improving Cerebral Blood Flow through Liposomal Delivery of Angiogenic Peptides: Potential of 18F-FDG PET Imaging in Ischemic Stroke Treatment.
    J Nucl Med. 2015 May 14. pii: jnumed.115.154443.
    PubMed     Text format     Abstract available


  337. JADVAR H
    PSMA PET in Prostate Cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157339.
    PubMed     Text format    


  338. BLASI F, Oliveira BL, Rietz TA, Rotile NJ, et al
    Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for positron emission tomography imaging of deep vein thrombosis and pulmonary embolism in rats.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157982.
    PubMed     Text format     Abstract available


  339. HUSMANN L, Sah BR, Scherrer A, Burger IA, et al
    18F-FDG-PET/CT FOR THERAPY CONTROL IN VASCULAR GRAFT INFECTIONS: A FIRST FEASIBILITY STUDY.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156265.
    PubMed     Text format     Abstract available


  340. NIEDERMOSER S, Chin J, Waengler C, Kostikov A, et al
    In vivo Evaluation of 18F-SiFAlin modified TATE: A Potential Challenge for 68Ga- DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with Positron Emission Tomography (PET).
    J Nucl Med. 2015 May 14. pii: jnumed.114.149583.
    PubMed     Text format     Abstract available


  341. CHATALIC KL, Veldhoven-Zweistra J, Bolkestein M, Hoeben S, et al
    A novel 111In-labeled anti-PSMA nanobody for targeted SPECT/CT imaging of prostate cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156729.
    PubMed     Text format     Abstract available


  342. MANBER R, Thielemans K, Hutton B, Barnes A, et al
    Practical PET Respiratory Motion Correction in Clinical PET/MR.
    J Nucl Med. 2015 May 7. pii: jnumed.114.151779.
    PubMed     Text format     Abstract available


  343. BEZRUKOV I, Schmidt H, Gatidis S, Mantlik F, et al
    Quantitative evaluation of segmentation- and atlas-based attenuation correction for PET/MR on pediatric patients.
    J Nucl Med. 2015 May 7. pii: jnumed.114.149476.
    PubMed     Text format     Abstract available


  344. MARCUS C, Marashdeh W, Ahn SJ, Taghipour M, et al
    FDG PET/CT & Colorectal Cancer: Value of Fourth and Subsequent Post Therapy follow up scans for Patient Management.
    J Nucl Med. 2015 May 7. pii: jnumed.115.156240.
    PubMed     Text format     Abstract available


  345. FIZ F, Morbelli S, Piccardo A, Bauckneht M, et al
    18F-NaF uptake by the atherosclerotic plaque at PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity.
    J Nucl Med. 2015 May 7. pii: jnumed.115.154229.
    PubMed     Text format     Abstract available


  346. PFEIFER A, Knigge U, Binderup T, Mortensen J, et al
    64Cu-DOTATATE PET for Neuroendocrine Tumors: a Prospective Head-to-Head Comparison with 111In-DTPA-octreotide in 112 Patients.
    J Nucl Med. 2015 May 7. pii: jnumed.115.156539.
    PubMed     Text format     Abstract available


  347. GOENSE L, van Rossum PS, Reitsma JB, Lam MG, et al
    Diagnostic performance of 18F-FDG and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis.
    J Nucl Med. 2015 May 7. pii: jnumed.115.155580.
    PubMed     Text format     Abstract available


  348. DELBEKE D
    The Era of Evidence-Based Medicine: What Are the Implications for JNM and Other Imaging Journals?
    J Nucl Med. 2015;56:28A.
    PubMed     Text format    


  349. HERSCOVITCH P
    Amyloid Imaging Coverage with Evidence Development and the IDEAS Study.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  350. KHALKHALI I
    Ismael Mena, MD, 1928-2015.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  351. CONTI PS
    Walter Wolf, PhD, 1931-2014.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  352. ZAMAN RT, Kosuge H, Carpenter C, Sun C, et al
    Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques.
    J Nucl Med. 2015;56:771-7.
    PubMed     Text format     Abstract available


  353. LAVERMAN P, van der Geest T, Terry SY, Gerrits D, et al
    Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
    J Nucl Med. 2015;56:778-83.
    PubMed     Text format     Abstract available


  354. HINDIE E, Zanotti-Fregonara P, Tabarin A, Rubello D, et al
    The role of radionuclide imaging in the surgical management of primary hyperparathyroidism.
    J Nucl Med. 2015;56:737-44.
    PubMed     Text format     Abstract available


  355. FAN Z, Harold D, Pasqualetti G, Williams J, et al
    Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    J Nucl Med. 2015;56:707-13.
    PubMed     Text format     Abstract available


  356. KHAIRNAR A, Marchand F, Vidal A, Etienne M, et al
    99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment.
    J Nucl Med. 2015;56:798-804.
    PubMed     Text format     Abstract available


  357. HAUSNER SH, Bauer N, Hu LY, Knight LM, et al
    The Effect of Bi-Terminal PEGylation of an Integrin alphavbeta(6)-Targeted (1)(8)F Peptide on Pharmacokinetics and Tumor Uptake.
    J Nucl Med. 2015;56:784-90.
    PubMed     Text format     Abstract available


  358. FAZIO P, Svenningsson P, Forsberg A, Jonsson EG, et al
    Quantitative Analysis of (1)(8)F-(E)-N-(3-Iodoprop-2-Enyl)-2beta-Carbofluoroethoxy-3beta-(4'-Methyl-Phenyl ) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    J Nucl Med. 2015;56:714-20.
    PubMed     Text format     Abstract available


  359. GLAUDEMANS AW, Slart RH, van Dijl JM, van Oosten M, et al
    Molecular imaging of infectious and inflammatory diseases: a terra incognita.
    J Nucl Med. 2015;56:659-61.
    PubMed     Text format    


    April 2015
  360. MAZERE J, Mayo W, Pariscoat G, Schulz J, et al
    Simplified quantification method for in vivo SPECT imaging of the Vesicular Acetylcholine Transporter with 123I-IBVM.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.147074.
    PubMed     Text format     Abstract available


  361. WANG H, Li D, Liu S, Liu R, et al
    Small animal PET imaging of pancreatic cancer xenografts using 64Cu labeled monoclonal antibody MAb159.
    J Nucl Med. 2015 Apr 23. pii: jnumed.115.155812.
    PubMed     Text format     Abstract available


  362. RUDD JH, Coughlin PA, Groves A
    Predicting aortic aneurysm expansion by PET.
    J Nucl Med. 2015 Apr 23. pii: jnumed.115.154062.
    PubMed     Text format    


  363. FAYAD H, Schmidt H, Wurslin C, Visvikis D, et al
    Reconstruction incorporated respiratory motion correction in clinical simultaneous PET/MR imaging for oncology applications.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.153007.
    PubMed     Text format     Abstract available


  364. WEBER WA, Gatsonis CA, Mozley PD, Hanna LG, et al
    Repeatability of 18F-FDG PET/CT in Advanced Non-small Cell Lung Cancer: Prospective Assessment in Two Multicenter Trials.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.147728.
    PubMed     Text format     Abstract available


  365. MEDINA RA, Mariotti E, Pavlovic D, Shaw KP, et al
    64CuCTS: a promising radiopharmaceutical for the identification of low grade cardiac hypoxia by PET.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.148353.
    PubMed     Text format     Abstract available


  366. SHI S, Orbay H, Yang Y, Graves SA, et al
    PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.153098.
    PubMed     Text format     Abstract available


  367. GRAHAM MM, Wahl RL, Hoffman JM, Yap JT, et al
    Summary of the UPICT Protocol for FDG PET/CT Imaging in Oncology Clinical Trials.
    J Nucl Med. 2015 Apr 16. pii: jnumed.115.158402.
    PubMed     Text format     Abstract available


  368. BENESOVA M, Schafer M, Bauder-Wust U, Afshar-Oromieh A, et al
    Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.147413.
    PubMed     Text format     Abstract available


  369. GROHEUX D, Sanna A, Majdoub M, de Cremoux P, et al
    Baseline tumor 18FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2- breast cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.115.154138.
    PubMed     Text format     Abstract available


  370. AZARBAR S, Salardini A, Dahdah N, Lazewatsky J, et al
    A phaseI-II, open-label, multi-center trial to determine the dosimetry and safety of Technetium Tc99m Sestamibi in pediatric subjects.
    J Nucl Med. 2015 Apr 9. pii: jnumed.114.146795.
    PubMed     Text format     Abstract available


  371. MEHRANIAN A, Zaidi H
    Clinical assessment of emission- and segmentation-based MRI-guided attenuation correction in whole-body TOF PET/MRI.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.154807.
    PubMed     Text format     Abstract available


  372. HOOGENDAM JP, Veldhuis WB, Hobbelink MG, Verheijen RH, et al
    Technetium-99m SPECT-CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and meta-analysis.
    J Nucl Med. 2015 Apr 9. pii: jnumed.114.152439.
    PubMed     Text format     Abstract available


  373. MCHUGH CI, Shields AF
    FLT-PET Evaluation of Radiation Response.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.155507.
    PubMed     Text format    


  374. RATIB O
    Shine-through artifact in PET/MRI: a perspective on its impact in clinical applications of PET-MR.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.155135.
    PubMed     Text format    


  375. LUO H, Hong H, Slater MR, Graves SA, et al
    PET of c-Met in cancer with 64Cu-labeled Hepatocyte Growth Factor.
    J Nucl Med. 2015 Apr 3. pii: jnumed.115.154690.
    PubMed     Text format     Abstract available


  376. INOUE Y, Nagahara K, Tanaka Y, Miyatake H, et al
    Methods of CT dose estimation in whole-body 18F-FDG PET/CT.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.153718.
    PubMed     Text format     Abstract available


  377. MINAMIMOTO R, Mosci C, Jamali M, Barkhodari A, et al
    Semiquantitative Analysis of the Biodistribution of the Combined 18F-NaF and 18F-FDG Administration for PET/CT Imaging.
    J Nucl Med. 2015 Apr 3. pii: jnumed.115.153767.
    PubMed     Text format     Abstract available


  378. WELLS RG, Wei L, Petryk J, Duan Y, et al
    Flow-dependent uptake of I-123-CMICE-013, a novel SPECT perfusion agent, compared to standard tracers.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.151563.
    PubMed     Text format     Abstract available


  379. MOSLEY M, Knight J, Neesse A, Michl P, et al
    Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.152496.
    PubMed     Text format     Abstract available



  380. Canadian NRU extended; medical isotope partnership announced.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  381. PAPPAS V
    SNMMI leadership update: SNMMI annual meeting heads to Baltimore.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  382. FAHEY F
    History Corner: from the new SNMMI historian.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  383. DORBALA S, Blankstein R, Skali H, Park MA, et al
    Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging.
    J Nucl Med. 2015;56:592-9.
    PubMed     Text format     Abstract available


  384. HUA C, Merchant TE, Li X, Li Y, et al
    Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children.
    J Nucl Med. 2015;56:575-9.
    PubMed     Text format     Abstract available


  385. BANERJEE SR, Foss CA, Pullambhatla M, Wang Y, et al
    Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.
    J Nucl Med. 2015;56:628-34.
    PubMed     Text format     Abstract available


  386. KOCH CJ, Evans SM
    Pharmacokinetic and pharmacodynamic modifiers of EF5 uptake and binding.
    J Nucl Med. 2015;56:653.
    PubMed     Text format    


  387. CHITNENI SK, Bida GT, Zalutsky MR, Dewhirst MW, et al
    Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
    J Nucl Med. 2015;56:653-4.
    PubMed     Text format    


    March 2015
  388. NAGARAJAH J, Ho AL, Tuttle RM, Weber WA, et al
    Correlation of BRAFV600E mutation and glucose metabolism in thyroid cancer patients: An 18F-FDG-PET study.
    J Nucl Med. 2015 Mar 26. pii: jnumed.114.150607.
    PubMed     Text format     Abstract available


  389. HANAOKA H, Ohshima Y, Suzuki Y, Yamaguchi A, et al
    Development of a Widely Usable Amino Acid Tracer: 76Br-alpha-Methyl-Phenylalanine for Tumor PET Imaging.
    J Nucl Med. 2015 Mar 26. pii: jnumed.114.152215.
    PubMed     Text format     Abstract available


  390. JAMAR F, Lhommel R
    Interim 18F-FDG-PET in diffuse large B-cell lymphoma : emerging worldwide?
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.151183.
    PubMed     Text format    


  391. MOREL O, Mandry D, Micard E, Kauffmann C, et al
    Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: a FDG-PET sequential observational study.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.146415.
    PubMed     Text format     Abstract available


  392. EIBER M, Maurer T, Souvatzoglou M, Beer AJ, et al
    Evaluation of hybrid 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2015 Mar 19. pii: jnumed.115.154153.
    PubMed     Text format     Abstract available


  393. DALM SU, Martens JW, Sieuwerts AM, van Deurzen CH, et al
    IN-VITRO AND IN-VIVO APPLICATION OF RADIOLABELED GASTRIN RELEASING PEPTIDE RECEPTOR LIGANDS IN BREAST CANCER.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.153023.
    PubMed     Text format     Abstract available


  394. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1: Statement of the Issue and a Review of Available Resources.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.152249.
    PubMed     Text format     Abstract available


  395. LYOO CH, Ikawa M, Liow JS, Zoghbi SS, et al
    Cerebellum can serve as a pseudo-reference region in Alzheimer's disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO).
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146027.
    PubMed     Text format     Abstract available


  396. KOLB A, Sauter AW, Eriksson LA, Vandenbrouke A, et al
    Shine-through in PET/MRI: effects of the magnetic field on positron range and subsequent image artifacts.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.147637.
    PubMed     Text format     Abstract available


  397. SCHWARZ SW, Oyama R
    The Role of Exploratory INDs for Translating Radiopharmaceuticals into First-In-Human Studies.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146472.
    PubMed     Text format     Abstract available


  398. TSENG JR, Lin CW, Chen SH, Yen TH, et al
    Clinical Usefulness of FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.151696.
    PubMed     Text format     Abstract available


  399. LANDAU SM, Fero A, Baker SL, Koeppe RA, et al
    Measurement of longitudinal A#946; change with 18F florbetapir PET and standard uptake value ratios.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148981.
    PubMed     Text format     Abstract available


  400. KANEKO Y, Murray WK, Link E, Hicks RJ, et al
    Improving patient selection for FDG-PET scanning in the staging of gastric cancer.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150946.
    PubMed     Text format     Abstract available


  401. CHEN K, Roontiva A, Thiyyagura P, Lee W, et al
    Improved power to characterize longitudinal amyloid-beta PET changes and evaluate amyloid-modifying treatments using a cerebral white matter reference region.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.149732.
    PubMed     Text format     Abstract available


  402. MEHRANIAN A, Zaidi H
    Impact of time-of-flight PET on quantification errors in MRI-based attenuation correction.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148817.
    PubMed     Text format     Abstract available


  403. EINSTEIN AJ, Johnson LL, DeLuca A, Kontak AC, et al
    Radiation Dose and Prognosis of Ultra-Low Dose Stress-First Myocardial Perfusion SPECT in Patients with Chest Pain Using a High-Efficiency Camera.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150664.
    PubMed     Text format     Abstract available


  404. JADVAR H, Subramaniam R, Berman CG, Boada F, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MRI: Brain.
    J Nucl Med. 2015 Mar 5. pii: jnumed.115.155218.
    PubMed     Text format    


  405. LIN KS, Amouroux G, Pan J, Zhang Z, et al
    Comparative Studies of Three Gallium-68-labeled [des-Arg10]Kallidin Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.152132.
    PubMed     Text format     Abstract available


  406. KNOOP K, Schwenk N, Schmohl K, Muller A, et al
    Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.146662.
    PubMed     Text format     Abstract available


  407. FREY KA
    Amyloid imaging in dementia: contribution or confusion?
    J Nucl Med. 2015;56:331-2.
    PubMed     Text format    


  408. THRALL JH
    Misinterpretation of 18F-FDG studies in oncology.
    J Nucl Med. 2015;56:494.
    PubMed     Text format    


  409. DELBEKE D
    JNM update for 2014.
    J Nucl Med. 2015;56:25A.
    PubMed     Text format    


  410. HERSCOVITCH P
    SNMMI leadership update: reaching out to develop a unified voice.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  411. Enrollment trends in technologist training.
    J Nucl Med. 2015;56:15N.
    PubMed     Text format    



  412. SNMMI industry forum created to work together on areas of promise.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  413. HERRMANN K, Lapa C, Wester HJ, Schottelius M, et al
    Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
    J Nucl Med. 2015;56:410-6.
    PubMed     Text format     Abstract available


  414. GARIN E, Rolland Y, Edeline J, Icard N, et al
    Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    J Nucl Med. 2015;56:339-46.
    PubMed     Text format     Abstract available


  415. DELSO G, Wiesinger F, Sacolick LI, Kaushik SS, et al
    Clinical evaluation of zero-echo-time MR imaging for the segmentation of the skull.
    J Nucl Med. 2015;56:417-22.
    PubMed     Text format     Abstract available


  416. KLUPP E, Grimmer T, Tahmasian M, Sorg C, et al
    Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    J Nucl Med. 2015;56:399-404.
    PubMed     Text format     Abstract available


  417. CABELLO J, Lukas M, Forster S, Pyka T, et al
    MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    J Nucl Med. 2015;56:423-9.
    PubMed     Text format     Abstract available


  418. CZUPRYNA J, Kachur AV, Blankemeyer E, Popov AV, et al
    Cerenkov-specific contrast agents for detection of pH in vivo.
    J Nucl Med. 2015;56:483-8.
    PubMed     Text format     Abstract available


  419. STEPHENSON NA, Holland JP, Kassenbrock A, Yokell DL, et al
    Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.
    J Nucl Med. 2015;56:489-92.
    PubMed     Text format     Abstract available


  420. TIMMERMAND OV, Tran TA, Strand SE, Axelsson J, et al
    Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    J Nucl Med. 2015;56:444-9.
    PubMed     Text format     Abstract available


  421. LAUTAMAKI R, Sasano T, Higuchi T, Nekolla SG, et al
    Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.
    J Nucl Med. 2015;56:457-63.
    PubMed     Text format     Abstract available


  422. GIORGETTI A, Burchielli S, Positano V, Kovalski G, et al
    Dynamic 3D analysis of myocardial sympathetic innervation: an experimental study using 123I-MIBG and a CZT camera.
    J Nucl Med. 2015;56:464-9.
    PubMed     Text format     Abstract available


  423. NAHIMI A, Jakobsen S, Munk OL, Vang K, et al
    Mapping alpha2 adrenoceptors of the human brain with 11C-yohimbine.
    J Nucl Med. 2015;56:392-8.
    PubMed     Text format     Abstract available


    February 2015
  424. HUET P, Burg S, Le Guludec D, Hyafil F, et al
    Variability and uncertainty of FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.142596.
    PubMed     Text format     Abstract available


  425. CHEN W, Dilsizian V
    PET Assessment of Vascular Inflammation and Atherosclerotic Plaques: SUV or TBR?
    J Nucl Med. 2015 Feb 26. pii: jnumed.115.154385.
    PubMed     Text format    


  426. SU Z, Roncaroli F, Durrenberger PF, Coope DJ, et al
    The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: A 11C-(R)PK11195 PET Imaging and Neuropathology Study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.151621.
    PubMed     Text format     Abstract available


  427. FANCHON LM, Dogan S, Moreira AL, Carlin SA, et al
    Feasibility for in situ, High Resolution Correlation of Tracer Uptake with Histopathology by Quantitative Autoradiography of Biopsy Specimens Obtained under FDG PET/CT Guidance.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148668.
    PubMed     Text format     Abstract available


  428. FENDLER WP, Lehmann M, Todica AS, Herrmann K, et al
    PET response criteria (PERCIST) predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.152462.
    PubMed     Text format     Abstract available


  429. ZHANG G, Li J, Wang X, Ma Y, et al
    The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: A pilot study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148254.
    PubMed     Text format     Abstract available


  430. JACOBSON O, Yan X, Gang N, Weiss ID, et al
    PET Imaging of Tenascin-C with a Radiolabeled Single-Strand DNA Aptamer.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.149484.
    PubMed     Text format     Abstract available


  431. BARRET O, Hannestad J, Vala C, Alagille D, et al
    Characterization in humans of 18F-MNI-444, a novel PET radiotracer for brain adenosine A2A receptors.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.152546.
    PubMed     Text format     Abstract available


  432. BIEGON A, Alexoff D, Kim SW, Logan J, et al
    Aromatase Imaging with [N-methyl-C-11]vorozole PET in Healthy Men and Women.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.150383.
    PubMed     Text format     Abstract available


  433. GURALNIK L, Rozenberg R, Frenkel A, Israel O, et al
    Metabolic PET/CT guided lung lesion biopsies - impact on diagnostic accuracy and rate of sampling error.
    J Nucl Med. 2015 Feb 19. pii: jnumed.113.131466.
    PubMed     Text format     Abstract available


  434. HOFMAN MS, Binns D, Johnston V, Siva S, et al
    Ga-68 EDTA PET/CT imaging and plasma clearance for glomerular filtration rate (GFR) quantification: comparison to conventional Cr-51 EDTA.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147843.
    PubMed     Text format     Abstract available


  435. IVASHCHENKO O, van der Have F, Goorden M, Ramakers R, et al
    Ultra-high-sensitivity sub-mm mouse SPECT.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147140.
    PubMed     Text format     Abstract available


  436. RAUSCHER I, Beer A, Schaeffeler C, Souvatzoglou M, et al
    Evaluation of 18F-Fluoride PET/MR and PET/CT in patients with unclear foot pain.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.150532.
    PubMed     Text format     Abstract available


  437. SAH BR, Burger IA, Schibli R, Friebe M, et al
    Dosimetry and first clinical evaluation of the new 18F radiolabeled Bombesin Analogue BAY 864367 in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147116.
    PubMed     Text format     Abstract available


  438. VERWER EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, et al
    Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.148007.
    PubMed     Text format     Abstract available


  439. WITHOFS N, Signolle N, Somja J, Lovinfosse P, et al
    18F-FPRGD2 PET/CT imaging of integrin alphavbeta3 in renal carcinomas: Correlation with histopathology.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149021.
    PubMed     Text format     Abstract available


  440. BEIJST C, Elschot M, Viergever MA, de Jong HW, et al
    A parallel cone collimator for high-energy SPECT.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149658.
    PubMed     Text format     Abstract available


  441. CHIRINDEL A, Chaudhry M, Blakeley J, Wahl RL, et al
    18F-FDG PET/CT qualitative and quantitative evaluation in NF1 patients for Detection of Malignant Transformation - comparison of early to delayed imaging with and without liver activity normalization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.142372.
    PubMed     Text format     Abstract available


  442. KOBYLECKI C, Langheinrich T, Hinz R, Vardy E, et al
    18F-florbetapir positron emission tomography in patients with frontotemporal dementia and Alzheimer's disease.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.147454.
    PubMed     Text format     Abstract available


  443. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Systematic evaluation of tumoral [Tc-99m]MAA-uptake using SPECT and SPECT/CT in 502 patients prior to Y-90 radioembolization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.150565.
    PubMed     Text format     Abstract available


  444. BAGEAC A
    Commentary: Quality: commandment and conundrum.
    J Nucl Med. 2015;56:9N-10N.
    PubMed     Text format    


  445. PAPPAS V
    SNMMI leadership update: Clinical Trials Network: from clinical trials to practice.
    J Nucl Med. 2015;56:12N.
    PubMed     Text format    


  446. PARKER JA
    ABNM international In-Training Examination program.
    J Nucl Med. 2015;56:10N.
    PubMed     Text format    


  447. WONDERGEM MJ, Rizvi SN, Jauw Y, Hoekstra OS, et al
    18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
    J Nucl Med. 2015;56:216-21.
    PubMed     Text format     Abstract available


  448. BAKKER G, Vingerhoets WA, van Wieringen JP, de Bruin K, et al
    123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    J Nucl Med. 2015;56:317-22.
    PubMed     Text format     Abstract available


  449. ILAN E, Sandstrom M, Wassberg C, Sundin A, et al
    Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
    J Nucl Med. 2015;56:177-82.
    PubMed     Text format     Abstract available


  450. ISHIBASHI K, Onishi A, Fujiwara Y, Ishiwata K, et al
    Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
    J Nucl Med. 2015;56:229-33.
    PubMed     Text format     Abstract available



  451. Abstracts of the AACR/SNMMI State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, February 11-14, 2015, San Diego, CA.
    J Nucl Med. 2015;56 Suppl 1:3A-28.
    PubMed     Text format    


    January 2015
  452. YU EY, Duan F, Muzi M, Deng X, et al
    Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from ACRIN 6687.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.146936.
    PubMed     Text format     Abstract available


  453. LEE SI, Catalano OA, Dehdashti F
    Gynecologic Cancer Imaging with MRI, FDG PET-CT and PET-MR.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.145011.
    PubMed     Text format     Abstract available


  454. RACHINGER W, Stoecklein VM, Terpolilli NA, Haug AR, et al
    Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumorfree tissue.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.149120.
    PubMed     Text format     Abstract available


  455. WALRAND S, Hesse M, Lhommel R, Jamar F, et al
    About the impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.152017.
    PubMed     Text format    


  456. MAKRIS NE, Boellaard R, van Lingen A, Lammertsma AA, et al
    PET/CT derived whole body and bone marrow dosimetry of 89Zr-cetuximab.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147819.
    PubMed     Text format     Abstract available


  457. JAMES ML, Belichenko NP, Nguyen TV, Andrews LE, et al
    PET imaging of translocator protein (18kDa) in a mouse model of Alzheimer's disease using 18F-PBR06.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.141648.
    PubMed     Text format     Abstract available


  458. MARCUS C, Paidpally V, Antoniou A, Zaheer A, et al
    FDG PET/CT & Lung Cancer: Value of Fourth and Subsequent Post Therapy follow up scans in Patient Management.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147884.
    PubMed     Text format     Abstract available


  459. LIN YC, Chen SW, Hsieh TC, Yen KY, et al
    Risk Stratification of Metastatic Neck Nodes by Computed Tomogram and Positron Emission Tomogram in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.148023.
    PubMed     Text format     Abstract available


  460. KRATOCHWIL C, Giesel FL, Leotta K, Eder M, et al
    PMPA for nephroprotection in PSMA-targeted radionuclide therapy of prostate cancer.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147181.
    PubMed     Text format     Abstract available


  461. NAGANAWA M, Zheng MQ, Henry S, Nabulsi N, et al
    Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the kappa opioid receptor.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.147975.
    PubMed     Text format     Abstract available


  462. WEHRL H, Sauter A, Divine MR, Pichler BJ, et al
    Combined PET/MR: a Technology Becomes Mature.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150318.
    PubMed     Text format     Abstract available


  463. HILLNER BE, Siegel BA, Hanna L, Duan F, et al
    18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150391.
    PubMed     Text format     Abstract available


  464. APPEL L, Jonasson M, Danfors T, Nyholm D, et al
    Use of 11C-PE2I Positron Emission Tomography in Differential Diagnosis of Parkinsonian Disorders.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.148619.
    PubMed     Text format     Abstract available


  465. AIRAS L, Dickens A, Elo P, Marjamaki PM, et al
    In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149955.
    PubMed     Text format     Abstract available


  466. FURST S, Grimm R, Hong I, Souvatzoglou M, et al
    Motion Correction Strategies for Integrated PET/MR.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146787.
    PubMed     Text format     Abstract available


  467. CALAIS J, Thureau S, Dubray B, Modzelewski R, et al
    High 18F-FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemo-radiotherapy for non-small cell lung cancer.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.144253.
    PubMed     Text format     Abstract available


  468. USLU L, Donig J, Link M, Rosenberg J, et al
    Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146290.
    PubMed     Text format     Abstract available


  469. LI Y, Tsui W, Rusinek H, Butler T, et al
    Cortical Lamina Binding of PET Amyloid and Tau Tracers in Alzheimer's disease.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149229.
    PubMed     Text format     Abstract available


  470. PRATO FS, Butler J, Sykes J, Keenliside L, et al
    Can The Inflammatory Response Be Evaluated Using 18F-FDG Within Zones of Microvascular Obstruction Following Myocardial Infarction?
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.147835.
    PubMed     Text format     Abstract available



  471. Nuclear medicine residency programs ranked.
    J Nucl Med. 2015;56:14N.
    PubMed     Text format    



  472. SNMMI leadership update: facilitation and collaboration to lead the future.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  473. Joint NCI/SNMMI workshop on targeted radionuclide therapy.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    



  474. SNMMI comments on NRC part 35 and part 20 rules.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  475. KUIK WJ, Kema IP, Brouwers AH, Zijlma R, et al
    In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
    J Nucl Med. 2015;56:106-12.
    PubMed     Text format     Abstract available


  476. WAYUA C, Low PS
    Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
    J Nucl Med. 2015;56:113-9.
    PubMed     Text format     Abstract available


    December 2014
  477. CIMITAN M, Evangelista L, Hodolic M, Mariani G, et al
    Gleason score at diagnosis predicts the detection rate of 18F-choline PET/CT performed at biochemical recurrence of prostate cancer: experience with 1,000 patients.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.141887.
    PubMed     Text format     Abstract available


  478. NENSA F, Tezgah E, Poeppel TD, Jensen CJ, et al
    Integrated 18F-FDG-PET/MRI in the assessment of cardiac masses: A pilot study.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.147744.
    PubMed     Text format     Abstract available


  479. VAN DIJK LK, Boerman OC, Franssen GM, Kaanders JH, et al
    Cetuximab-F(ab')2-SPECT and FDG-PET for prediction and response monitoring of combined modality treatment of human head and neck carcinomas in a mouse model.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.148296.
    PubMed     Text format     Abstract available


  480. OYEN WJ, de Jong IJ
    Molecular imaging of prostate cancer : tapping into the opportunities.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.150219.
    PubMed     Text format    


  481. JANSEN N, Suchorska B, Wenter V, Schmid-Tannwald C, et al
    Prognostic Significance of Dynamic 18F-FET-PET in Newly Diagnosed Astrocytic High Grade Glioma.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.144675.
    PubMed     Text format     Abstract available


  482. BONDUE B, Sherer F, Van Simaeys G, Doumont G, et al
    PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.147421.
    PubMed     Text format     Abstract available


  483. JHAVERI K, Linden H
    Measuring Tumor Metabolism by FDG PET predicts outcome in a multicenter study: A step-off in the right direction.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.151175.
    PubMed     Text format    


  484. PARK JW, Jung K, Lee JH, Quach CH, et al
    18F-FDG PET/CT Monitoring of beta3 Agonist-Stimulated Brown Adipocyte Recruitment in White Adipose Tissue.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147603.
    PubMed     Text format     Abstract available


  485. KANG C, Lin C, Yang L, Ho T, et al
    Positive Clinical Impact of an Additional PET/CT Scan before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145300.
    PubMed     Text format     Abstract available


  486. PARK SY, Cho A, Yu WS, Lee CY, et al
    Prognostic value of total lesion glycolysis by18F-fluorodeoxyglucose positron emission tomography/computed tomography in surgically resected stage IA non-small cell lung cancer.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147561.
    PubMed     Text format     Abstract available


  487. FLETCHER JW, Logan TF, Eitel JA, Mathias CJ, et al
    Whole-body PET/CT Evaluation of Tumor Perfusion using Generator-based 62Cu-ETS: Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148106.
    PubMed     Text format     Abstract available


  488. DUNKL V, Cleff C, Stoffels G, Judov N, et al
    The usefulness of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148734.
    PubMed     Text format     Abstract available


  489. HUANG HJ, Isakow W, Byers DE, Engle JT, et al
    Imaging pulmonary iNOS expression with positron emission tomography.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.146381.
    PubMed     Text format     Abstract available


  490. SURTI S
    Update in time-of-flight PET imaging.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145029.
    PubMed     Text format     Abstract available


  491. SUNDERLAND JJ, Christian PE
    Quantitative PET/CT scanner performance characterization based upon the Clinical Trials Network oncology clinical simulator phantom.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148056.
    PubMed     Text format     Abstract available


  492. KREISL WC, Bhatia R, Morse CL, Woock AE, et al
    Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.146894.
    PubMed     Text format     Abstract available


  493. BURGER IA, Wurnig MC, Becker A, Kenkel D, et al
    Hybrid PET/MRI: An Algorithm to reduce Metal Artifacts from Dental Implants in Dixon-based Attenuation Map Generation using a MAVRIC sequence.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.145862.
    PubMed     Text format     Abstract available


  494. HATT M, Majdoub M, Vallieres M, Tixier F, et al
    FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.144055.
    PubMed     Text format     Abstract available


  495. HERRMANN K, Czernin J, Wolin EM, Gupta P, et al
    Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.148247.
    PubMed     Text format     Abstract available


  496. CHEN CJ, Bando K, Ashino H, Taguchi K, et al
    In Vivo SPECT Imaging of Amyloid-beta Deposition with Radioiodinated Imidazo[1,2-alpha]pyridine Derivative DRM106 in Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.146944.
    PubMed     Text format     Abstract available


  497. SHALGUNOV V, van Wieringen JP, Janssen H, Fransen PM, et al
    Synthesis And Evaluation In Rats Of The Dopamine D2/3 Receptor Agonist 18F-AMC20 As Potential Radioligand For PET.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.145466.
    PubMed     Text format     Abstract available


  498. CONNOLLY RM, Leal JP, Goetz MP, Zhang Z, et al
    TBCRC 008: Early change in 18-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) predicts response to preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144741.
    PubMed     Text format     Abstract available


  499. OOSTING SF, Brouwers AH, van Es SC, Nagengast WB, et al
    89Zr-bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Anti-angiogenic Treatment.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144840.
    PubMed     Text format     Abstract available


  500. KIM M, Achmad A, Higuchi T, Arisaka Y, et al
    Effects of intra-tumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-FAMT PET/CT in oral squamous cell carcinoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144014.
    PubMed     Text format     Abstract available


  501. VAN KRUCHTEN M, de Vries EF, Arts HJ, Jager NM, et al
    Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients using 18F-FES-PET/CT.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.147579.
    PubMed     Text format     Abstract available


  502. CERCI JJ, Fanti S, Redondo F, Gyorke T, et al
    Reply: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.150086.
    PubMed     Text format    


  503. ADAMS H, Kwee TC
    Letter: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148577.
    PubMed     Text format    


  504. KIM EE
    Nuclear Medicine: A Guide for Healthcare Professionals and Patients.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148809.
    PubMed     Text format    


  505. KIM EE
    Radiology for PET/CT Reporting.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148692.
    PubMed     Text format    



  506. 2014 Cassen Lecture: What Have We Learned from the National Oncologic PET Registry?
    J Nucl Med. 2014;55:9N-15N.
    PubMed     Text format    


  507. KIM EE
    Clinical Applications of SPECT-CT.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  508. KIM EE
    PET/MRI: Methodology and Clinical Applications.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  509. DORAN MG, Watson PA, Cheal SM, Spratt DE, et al
    Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET.
    J Nucl Med. 2014;55:2045-9.
    PubMed     Text format     Abstract available


  510. ROUZET F, Chequer R, Benali K, Lepage L, et al
    Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis.
    J Nucl Med. 2014;55:1980-5.
    PubMed     Text format     Abstract available


  511. HILLMER AT, Wooten DW, Bajwa AK, Higgins AT, et al
    First-in-Human Evaluation of 18F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors.
    J Nucl Med. 2014;55:1973-9.
    PubMed     Text format     Abstract available


  512. FENG L, Svarer C, Thomsen G, de Nijs R, et al
    In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4'-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamid e SPECT.
    J Nucl Med. 2014;55:1966-72.
    PubMed     Text format     Abstract available


  513. O'BRIEN JT, Firbank MJ, Davison C, Barnett N, et al
    18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias.
    J Nucl Med. 2014;55:1959-65.
    PubMed     Text format     Abstract available


  514. GRUENEISEN J, Schaarschmidt BM, Beiderwellen K, Schulze-Hagen A, et al
    Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies.
    J Nucl Med. 2014;55:1930-5.
    PubMed     Text format     Abstract available


  515. KARANTANIS D, Kalkanis D, Czernin J, Herrmann K, et al
    Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.
    J Nucl Med. 2014;55:1925-9.
    PubMed     Text format     Abstract available


  516. SIEGEL JA, Stabin MG
    Medical imaging: the challenges of radiation risk assessment.
    J Nucl Med. 2014;55:16N-17N.
    PubMed     Text format    


  517. IWAMOTO M, Kawada K, Nakamoto Y, Itatani Y, et al
    Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS.
    J Nucl Med. 2014;55:2038-44.
    PubMed     Text format     Abstract available


  518. CORNELISSEN B, Able S, Kartsonaki C, Kersemans V, et al
    Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer.
    J Nucl Med. 2014;55:2026-31.
    PubMed     Text format     Abstract available


  519. CHENG DW, Ersahin D, Staib LH, Della Latta D, et al
    Using SUV as a guide to 18F-FDG dose reduction.
    J Nucl Med. 2014;55:1998-2002.
    PubMed     Text format     Abstract available


  520. SCHUSTER DM, Nanni C, Fanti S, Oka S, et al
    Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.
    J Nucl Med. 2014;55:1986-92.
    PubMed     Text format     Abstract available


  521. HICKS RJ
    The customer is always right, even when you are justifiably wrong.
    J Nucl Med. 2014;55:1923-4.
    PubMed     Text format    


  522. JAGER NA, Westra J, Golestani R, van Dam GM, et al
    Folate receptor-beta imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque.
    J Nucl Med. 2014;55:1945-51.
    PubMed     Text format     Abstract available


    November 2014
  523. MURTHY VL, Lee BC, Sitek A, Naya M, et al
    Comparison and Prognostic Validation of Multiple Methods of Quantification of Myocardial Blood Flow with 82Rb PET.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145342.
    PubMed     Text format     Abstract available


  524. CARR R, Fanti S, Paez D, Cerci JJ, et al
    Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145326.
    PubMed     Text format     Abstract available


  525. PRESTWICH R, Sen M, Scarsbrook A
    Letter: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148114.
    PubMed     Text format    


  526. SUBRAMANIAM RM
    Reply: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148379.
    PubMed     Text format    


  527. CHATALIC KL, Franssen GM, van Weerden WM, McBride WJ, et al
    Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.141143.
    PubMed     Text format     Abstract available


  528. CAOBELLI F, Ren Kaiser S, Thackeray JT, Bengel FM, et al
    IQ SPECT Allows a Significant Reduction in Administered Dose and Acquisition Time for Myocardial Perfusion Imaging: Evidence from a Phantom Study.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143560.
    PubMed     Text format     Abstract available


  529. BOILEAU I, Bloomfield PM, Rusjan PM, Mizrahi R, et al
    Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.146464.
    PubMed     Text format     Abstract available


  530. ROY S, Wang WT, Carass A, Prince JL, et al
    PET Attenuation Correction Using Synthetic CT from Ultrashort Echo-Time MR Imaging.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143958.
    PubMed     Text format     Abstract available



  531. SNMMI Leadership Update: The Importance of Quality, Evidence, and Value in Nuclear Medicine.
    J Nucl Med. 2014;55:26N.
    PubMed     Text format    


  532. KIM EE
    Whole-Body FDG PET Imaging in Oncology: Clinical Reports.
    J Nucl Med. 2014;55:1915.
    PubMed     Text format    


  533. MAHMOOD U
    2014 SNMMI highlights lecture: Oncology.
    J Nucl Med. 2014;55:9N-24N.
    PubMed     Text format    


  534. SEGALL G
    Enhancing the value of MOC.
    J Nucl Med. 2014;55:25N.
    PubMed     Text format    


  535. TERRY SY, Abiraj K, Lok J, Gerrits D, et al
    Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
    J Nucl Med. 2014;55:1849-55.
    PubMed     Text format     Abstract available


  536. ZHOU X, Chen R, Xie W, Ni Y, et al
    Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    J Nucl Med. 2014;55:1766-71.
    PubMed     Text format     Abstract available


  537. INOUE K, Gibbs SL, Liu F, Lee JH, et al
    Microscopic validation of macroscopic in vivo images enabled by same-slide optical and nuclear fusion.
    J Nucl Med. 2014;55:1899-904.
    PubMed     Text format     Abstract available


  538. GJERLOFF T, Jakobsen S, Nahimi A, Munk OL, et al
    In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    J Nucl Med. 2014;55:1818-24.
    PubMed     Text format     Abstract available


  539. KRULL KR, Minoshima S, Edelmann M, Morris B, et al
    Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation.
    J Nucl Med. 2014;55:1805-10.
    PubMed     Text format     Abstract available


  540. HEISS WD
    Radionuclide imaging in ischemic stroke.
    J Nucl Med. 2014;55:1831-41.
    PubMed     Text format     Abstract available


  541. DE PROST N, Feng Y, Wellman T, Tucci MR, et al
    18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndrome.
    J Nucl Med. 2014;55:1871-7.
    PubMed     Text format     Abstract available


  542. SATTLER B, Kranz M, Starke A, Wilke S, et al
    Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
    J Nucl Med. 2014;55:1885-92.
    PubMed     Text format     Abstract available


  543. BODEI L, Kidd M, Baum RP, Modlin IM, et al
    PRRT: Defining the paradigm shift to achieve standardization and individualization.
    J Nucl Med. 2014;55:1753-6.
    PubMed     Text format     Abstract available


  544. BASU S, Ostwal V, Ranade R, Panda D, et al
    Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management.
    J Nucl Med. 2014;55:1916-7.
    PubMed     Text format    


    October 2014
  545. SHAM JG, Kievit FM, Grierson JR, Chiarelli PA, et al
    Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma.
    J Nucl Med. 2014 Oct 30. pii: jnumed.114.145102.
    PubMed     Text format     Abstract available


  546. LIN LT, Chang CH, Yu HL, Liu RS, et al
    Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome-Embedded 188Re on Human Non-Small Cell Lung Cancer Using an Orthotopic Small-Animal Model.
    J Nucl Med. 2014 Oct 27. pii: jnumed.114.140418.
    PubMed     Text format     Abstract available


  547. SCHILLACI O
    Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.147538.
    PubMed     Text format    


  548. VALLABHAJOSULA S, Nikolopoulou A, Babich JW, Osborne JR, et al
    99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.140426.
    PubMed     Text format     Abstract available


  549. JENTZEN W, Hoppenbrouwers J, van Leeuwen P, van der Velden D, et al
    Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging.
    J Nucl Med. 2014 Oct 20. pii: jnumed.114.144089.
    PubMed     Text format     Abstract available


  550. VERWER EE, Bahce I, van Velden FH, Yaqub M, et al
    Parametric Methods for Quantification of 18F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2014 Oct 16. pii: jnumed.114.141846.
    PubMed     Text format     Abstract available


  551. SIMSEK DH, Kuyumcu S, Turkmen C, Sanli Y, et al
    Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
    J Nucl Med. 2014 Oct 14. pii: jnumed.114.142224.
    PubMed     Text format     Abstract available


  552. PAUL S, Khanapur S, Elsinga PH, Ishiwata K, et al
    PET Imaging of Adenosine A1 Receptor Occupancy.
    J Nucl Med. 2014 Oct 9. pii: jnumed.114.147736.
    PubMed     Text format    


  553. BAHRI H, Laurence L, Edeline J, Leghzali H, et al
    High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation.
    J Nucl Med. 2014 Oct 6. pii: jnumed.114.144386.
    PubMed     Text format     Abstract available


  554. IZQUIERDO-GARCIA D, Hansen AE, Forster S, Benoit D, et al
    An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging.
    J Nucl Med. 2014 Oct 2. pii: jnumed.113.136341.
    PubMed     Text format     Abstract available


  555. RYLOVA SN, Barnucz E, Barnucz E, Fani M, et al
    Does Imaging alphavbeta3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy?
    J Nucl Med. 2014 Oct 2. pii: jnumed.114.137570.
    PubMed     Text format     Abstract available


  556. MANSI L, Cuccurullo V
    Diagnostic imaging in neuroendocrine tumors.
    J Nucl Med. 2014;55:1576-7.
    PubMed     Text format    


  557. MORGAT C, Mishra AK, Varshney R, Allard M, et al
    Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors.
    J Nucl Med. 2014;55:1650-7.
    PubMed     Text format     Abstract available


  558. BROISAT A, Toczek J, Dumas LS, Ahmadi M, et al
    99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
    J Nucl Med. 2014;55:1678-84.
    PubMed     Text format     Abstract available


  559. SUZUKI C, Tsuji AB, Kato K, Kikuchi T, et al
    Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
    J Nucl Med. 2014;55:1671-7.
    PubMed     Text format     Abstract available


  560. BARRET O, Hannestad J, Alagille D, Vala C, et al
    Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    J Nucl Med. 2014;55:1712-8.
    PubMed     Text format     Abstract available


  561. DEMEURE F, Hanin FX, Bol A, Vincent MF, et al
    A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    J Nucl Med. 2014;55:1629-35.
    PubMed     Text format     Abstract available


  562. BRUST P, Deuther-Conrad W, Becker G, Patt M, et al
    Distinctive in vivo kinetics of the new sigma1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.
    J Nucl Med. 2014;55:1730-6.
    PubMed     Text format     Abstract available


  563. MULLER C, Bunka M, Haller S, Koster U, et al
    Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.
    J Nucl Med. 2014;55:1658-64.
    PubMed     Text format     Abstract available


    September 2014
  564. BURGER IA, Zitzmann-Kolbe S, Pruim J, Friebe M, et al
    First Clinical Results of (d)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.140699.
    PubMed     Text format     Abstract available


  565. BEAINO W, Anderson CJ
    PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.144881.
    PubMed     Text format     Abstract available


  566. LIU C, Sinusas AJ
    Is Assessment of Absolute Myocardial Perfusion with SPECT Ready for Prime Time?
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.144550.
    PubMed     Text format    


  567. VAN DIJK LK, Boerman OC, Franssen GM, Lok J, et al
    Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab')2-SPECT After Radiotherapy of Human Head And Neck Squamous Cell Carcinomas in a Mouse Model.
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.141762.
    PubMed     Text format     Abstract available


  568. CERCI JJ, Gyorke T, Fanti S, Paez D, et al
    Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Sep 11. pii: jnumed.113.134486.
    PubMed     Text format     Abstract available


  569. RIEDL CC, Slobod E, Jochelson M, Morrow M, et al
    Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.143297.
    PubMed     Text format     Abstract available


  570. HUANG W, Fan M, Liu B, Fu Z, et al
    Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.142919.
    PubMed     Text format     Abstract available


  571. WELLS RG, Timmins R, Klein R, Lockwood J, et al
    Dynamic SPECT Measurement of Absolute Myocardial Blood Flow in a Porcine Model.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.139782.
    PubMed     Text format     Abstract available


  572. KAMSON DO, Lee TJ, Varadarajan K, Robinette NL, et al
    Clinical Significance of Tryptophan Metabolism in the Nontumoral Hemisphere in Patients with Malignant Glioma.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.141002.
    PubMed     Text format     Abstract available



  573. A new focus on women in nuclear medicine.
    J Nucl Med. 2014;55:15N.
    PubMed     Text format    


  574. SHAH M, Seibyl J, Cartier A, Bhatt R, et al
    Molecular imaging insights into neurodegeneration: focus on alpha-synuclein radiotracers.
    J Nucl Med. 2014;55:1397-400.
    PubMed     Text format     Abstract available


  575. KIM YI, Phi JH, Paeng JC, Choi H, et al
    In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease.
    J Nucl Med. 2014;55:1467-72.
    PubMed     Text format     Abstract available


  576. GRAHAM MM
    Ventilation-perfusion lung scanning: stuck in a rut?
    J Nucl Med. 2014;55:1395-6.
    PubMed     Text format    


  577. XIE T, Zaidi H
    Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
    J Nucl Med. 2014;55:1459-66.
    PubMed     Text format     Abstract available


  578. WITNEY TH, Pisaneschi F, Alam IS, Trousil S, et al
    Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
    J Nucl Med. 2014;55:1506-12.
    PubMed     Text format     Abstract available


  579. WILKS MQ, Knowles SM, Wu AM, Huang SC, et al
    Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.
    J Nucl Med. 2014;55:1539-44.
    PubMed     Text format     Abstract available


  580. LIU Z, Pourghiasian M, Benard F, Pan J, et al
    Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
    J Nucl Med. 2014;55:1499-505.
    PubMed     Text format     Abstract available


    August 2014
  581. ETCHEBEHERE EC, de Oliveira Santos A, Gumz B, Vicente A, et al
    68Ga-DOTATATE PET/CT, 99mTc-HYNIC-Octreotide SPECT/CT, and Whole-Body MR Imaging in Detection of Neuroendocrine Tumors: A Prospective Trial.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.144543.
    PubMed     Text format     Abstract available


  582. PREVRHAL S, Heinzer S, Wulker C, Renisch S, et al
    Fat-Constrained 18F-FDG PET Reconstruction in Hybrid PET/MR Imaging.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.139758.
    PubMed     Text format     Abstract available


  583. MACHULLA HJ, Malik N
    Fatty Acids as a Concept for Probes in Cardiologic PET/MR Imaging.
    J Nucl Med. 2014 Aug 25. pii: jnumed.114.146142.
    PubMed     Text format    


  584. GOURNI E, Mansi R, Jamous M, Waser B, et al
    N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.141242.
    PubMed     Text format     Abstract available


  585. THURFJELL L, Lilja J, Lundqvist R, Buckley C, et al
    Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.142109.
    PubMed     Text format     Abstract available


  586. CHOI H, Cheon GJ, Kim HJ, Choi SH, et al
    Segmentation-Based MR Attenuation Correction Including Bones Also Affects Quantitation in Brain Study: An Initial Result of 18F-FP-CIT PET/MR for Patients with Parkinsonism.
    J Nucl Med. 2014 Aug 11. pii: jnumed.114.138636.
    PubMed     Text format     Abstract available


  587. LEE SH, Oh BM, Lee G, Choi H, et al
    Feasibility of 18F-FDG PET as a Noninvasive Diagnostic Tool of Muscle Denervation: A Preliminary Study.
    J Nucl Med. 2014 Aug 7. pii: jnumed.114.140731.
    PubMed     Text format     Abstract available


    May 2014
  588. PERISINAKIS K, Seimenis I, Tzedakis A, Damilakis J, et al
    Perfusion Scintigraphy Versus 256-Slice CT Angiography in Pregnant Patients Suspected of Pulmonary Embolism: Comparison of Radiation Risks.
    J Nucl Med. 2014 May 29. pii: jnumed.114.137968.
    PubMed     Text format     Abstract available


  589. VAN GOOL MH, Aukema TS, Schaake EE, Rijna H, et al
    Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non-Small Cell Lung Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


    April 2014
  590. LUTJE S, Rijpkema M, Franssen GM, Fracasso G, et al
    Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: